agenda 7 fme mea nephrology forum hilton vienna 1st fileagenda 7th fme mea nephrology forum hilton...

7th FME/MEA Nephrology Forum

Agenda 7th FME MEA Nephrology Forum Hilton Vienna 1st - 3rd August 2010

Day 1 (2 August 2010)

9.00-9.30 Hypertension in the General Population and in Patients with ESRD Epidemiology & Pathogenesis

Professor Dr. Eberhard Ritz

Prof. Dr. Eberhard Ritz Prof. Dr. A. Meguid El Nahas

9.30-10.00 Reno- vascular Hypertension Professor. Dr.Adel Afifi

10.00- 10.30 Treatment Hypertension – When and How are Lifestyle Interventions useful?

Professor Dr.Abdel Meguid El Nahas

10.30-11.00 Panel discussion

11.00-11.30 Break

11.30-12,00 Hypertension in renal transplant patient: Diagnostic and therapeutic approach.

Dr. Antoine Barbari, MD Prof. Dr. Eberhard Ritz 12.00-12,30 Volume Overload and Blood

Pressure: Facts and Fiction Results from the European BCM study in PD patients

Professor. Van Biesen

12.30- 13.00 Panel discussion

13.00-14.00 Lunch

14.00-15.00 PD Case Studies Prof. Van Biesen Prof. Dr. A. Meguid El Nahas 15.00-16.00 Heart-Kidney Interaction: The

cardio-renal syndrome Prof. Swanepoel

Time Topic Speaker Chairmen

Opening lecture (1 August 2010)

7.00 – 7.30 7.30 – 8.15 8.15 - 10.00

Reception Cocktail “To dates silent white killers in dialysis” Dinner

Prof. Jorg Vienken

Dr. Aly Elkhodiry Mr. C. Puth Mr. J. Seyfang


Time Topic Speaker Chairmen

Day 2 (3August 2010)

9.00-9.35 Pharmacological Treatment of Hypertension in CKD I – IV patients

Professor Dr. Rashad Barsoum

Professor Dr. R.Barsoum Professor Dr. B. Canaud

9.35-10.10 Hypertension in Dialysis Patients – How to manage it

Dr. Peter Blankestijn

10.10- 10.45 Dialysis Quality Update 2010 – What is important to know

Professor Dr. Bernard Canaud

10.45- 11.00 Questions to panel of presenters

11.00-11,30 Break

11.30– 12.00 CRRT – Patients with High Risk Bleeding tendency and treatment overview

Dr. Slowinski Professor Swanepoel

12.00- 12.30 Resistant hypertension a challenge for the nephrologist

Dr. Soliman Karsou

12.30- 13.00 Questions to panel of presenters

13.00-14.00 Lunch Break

14.00-15.30 Case Studies

Evaluation, Certificates and Closing

Professor Dr. R.Barsoum


Professor Jörg Vienken

has a degree in Chemical Engineering from the Technical University of Darmstadt and a Doctoral Degree in Biophysics &

Engineering from the Technical University of Aachen (RWTH), both in Germany.

After working as an Associate Professor at the Institute for Biotechnology at Würzburg University, he is now working in the

medical device industry for more than 25 years with focus on medical device technology, biomaterials and artificial organs.

Until moving to his recent position as Vice President "BioSciences" at Fresenius Medical Care in Bad Homburg, he was Head

of the Department of Scientific Services at Akzo Nobel Membrana, Wuppertal, both in Germany.


Jörg Vienken has authored/co-authored more than 250 publications and 5 books with subject to biological and artificial

membranes, biomaterials, biocompatibility and nephrology issues, as well as on Artificial Organs. He is member of the

Editorial Board of several scientific journals dedicated to Biomaterials, Artificial Organs and Medical Device Technology.

After serving for 8 years as Treasurer of the European Society for Artificial Organs (ESAO), Prof. Jörg Vienken has been

appointed as “co-opted member” of the ESAO board.

In 2009, Prof. Vienken has been elected as President of the International Federation for Artificial Organs (IFAO), the umbrella

organization of the continental Artificial Organ Societies in Europe, USA and Japan (ESAO, ASAIO and JSAO).

Since many years, he provides his experience to Academia as lecturer at the Technical Universities of Aachen, Hannover and

Ilmenau, at the private European University for Applied Sciences "EFF" in Idstein (all in Germany), at the Danube University

in Krems, Austria, and as a Professor at the International Faculty of Artificial Organs (INFA).

He is Member of the Academic Leibniz-Sozietät in Berlin, Germany.


Professor Dr. Eberhard Ritz

Professor Dr. Eberhard Ritz is affiliated with the Department Internal Medicine, Ruperto Carola University of Heidelberg,

Germany.

He was born on January 23rd, 1938, in Heidelberg and studied medicine in the Medical Schools of Heidelberg, Munich and

Montpellier. He worked at the Department Internal Medicine Zürich (Switzerland) and subsequently as an NIH postdoctoral

fellow at the Department of Biochemistry, Washington, University of St. Louis.


Since 1967 he worked in the Department of Internal Medicine, University of Heidelberg, where he was promoted to become

Professor of Internal Medicine in 1974 and then chief of the Division of Nephrology in 1977.He is professor emeritus since

April 2003.

His main interests concern calcium metabolism in renal failure, hypertension and the kidney, diabetic nephropathy and cardiac

problems in renal failure.

He is past president of the "Gesellschaft für Nephrologie" and past council member of the European Renal Association and

council member of the International Society of Nephrology. He was president of the World Congress of Nephrology, June 2003

in Berlin. He is honorary member of the European Renal Association (ERA/EDTA) and of the Australian, British, Czech ,

French, Italian, Polish, Spanish and South African Societies of Nephrology. He is member of the American College of

Physicians and the Royal College of Physicians in London and Edinburgh respectively.

He is recipient of the distinguished investigator medal of the National Kidney Foundation, the "Wissenschaftspreis der

Deutschen Hochdruckliga" and the "Bundesverdienstkreuz" of the German government. He is Dr.h.c. of the Silesian School of

Medicine, the Pomerian School of Medicine and of Semmelweis University Budapest/Hungary and recipient of the Jacob

Henle medal of the University Goettingen.

He received the John P. Peters award of the American Society of Nephrology 2003.

He was congress president of the World Congress of Nephrology Berlin, June 8-12th, 2003.

He is editor-in-chief emeritus of Nephrology Dialysis Transplantation and currently associate editor of the Journal American

Society of Nephrology.

He is currently president of the International Society of Nephrology.


Professor Dr.Dr.med.h.c.mult. Eberhard Ritz

Department Internal Medicine – Ruperto Carola University

Nierenzentrum

Im Neuenheimer Feld 162

D-69120 Heidelberg

Tel.: -6221/601705

Fax: -6221/603302

eMail: [email protected]

mailto:[email protected]


Professor Dr. Rashad Sami Barsoum

Born in Assiut, Egypt, July 3rd, 1941.

Married to Dr. Mona Tawfik Farid, father of three daughters, Noha, Nadine and Mireille and grandfather of

Alexander and Daniel

Qualifications: Bachelor degree, Kasr-El-Aini Medical School, Cairo University. (MB,BCh with honors): June 1963.

o Golden Medals of Distinction in Physiology (1959), Toxicology (1961) and Internal Medicine (1962)

USA equivalent graduate certification (ECFMG). February 1971.

Diploma of Internal Medicine (DM with distinction), Cairo University: October 1964.

Doctorate in Internal Medicine (MD), Cairo University: June 1969.

Membership of the Royal College of Physicians (MRCP UK): April 1972.

Fellowship of the Royal College of Physicians of Edinburgh (FRCPE): November 1982.

Fellowship of the Royal College of Physicians of London (FRCP): June 1986.


Training and Fellowships: Registrar in Internal Medicine, Cairo University: 1963-1965.

Fellow in Nephrology, Cairo University: 1965-1967.

Clinical Demonstrator in Nephrology, Cairo University: 1967-1969.

Fellow in Nephrology, University of Paris (Hôpital Tenon): 1970.

Nephrology Registrar, Urology Institute of London: 1971.

WHO Fellow in Nephrology, University of, Minnesota, Minneapolis, USA: 1975.

Medals, Honors and Awards:

International

International Award of the National Kidney Foundation of the USA: Baltimore: 1992

The Roscoe Robinson Award of the International Society of Nephrology, Rio de Janeiro, 2007

Regional

First & 2nd International Conferences of Biomedical Engineering, Cairo: 1979, 1981.

Pan African Pediatric Nephrology Association, Cairo 2000

Arab Society of Nephrology and Renal Transplantation, 2000, 2004

Arab Association of Pediatric Nephrology Riyadh, 2000

Middle East Society of Organ Transplantation, Muscat, 2002

Jordanian Society of Nephrology 2009

Sudanese Society of Nephrology 2010

National

Egyptian Society of Urology: 1981.

Egyptian Society of Nephrology: 1986, 2000, 2005.

Egyptian Medical Syndicate: 1995, 1998

Egyptian Society of Pediatric Nephrology, 2000


Institutional

Cairo University Medical School, 2001

Mansoura University, 2003, 2009

Assiut University, 2003

Egyptian Military Academy, 2003

Menya University, 2005

Best Researcher Award, Cairo University, 2007

Cairo Rotary Club, 2010

Academic appointments:

Cairo University:

Lecturer in Internal Medicine: 1969-1974.

Assistant Professor of Internal Medicine: 1974-1979.

Professor of Internal Medicine: 1979 - 2001

Chief of Nephrology: 1988 -2001

Head Professorial Unit of Internal Medicine: 1992-2001

Founding Chairman of Kasr-El-Aini Nephrology and Dialysis Center: 1994-2001

Chairman of the Department of Internal Medicine, 1999-2001

Emeritus Professor of Medicine: 2001-

Invited Member of the Faculty Council (2006--2007)

Member of the Wisdom Committee (2006-)

Supreme Council for Egyptian Universities

Member of the State's Standing Committee for Professorial Appointment in Internal Medicine: 1989 - 1995;

Secretary General 1998-2001, Ex-officio member 2004-2007.

Member of the Commission for Post-graduate Medical Education, Medical Sector, Supreme Council of Egyptian

Universities, 2001-2004

Chairman of the Commission for Education of Internal Medicine, Medical Sector, Supreme Council of Egyptian

Universities, 2002-2004


Chairman, Medical Sector, Supreme Council of Egyptian Universities 2008--

Egyptian National Research Academy

Member of National Committee for the National Award in Medical Sciences, 1995--

Members of the National Committee for the Mohammed Fakhry Prize for distinction in Medical Sciences, 1996-

2009

Member of the National Committee for the Mansoura International Award for distinction in Nephro-urology, 1996-

2009

Visiting Professor:

Khartoum University, Sudan: 1982.

University of Madagascar, Tananarivo, Madagascar: 1986.

University Hospital Beni Messous, Algiers, Algeria: 1986 & 1987.

Zahra University Hospital, Tripoli, Libya: 1990.

Downstate Medical Center, Southern University, New York: 1994.

Sheffield Kidney Institute, Sheffield UK: 1995--

Danube University, Kermes Austria: 1997.

University of Los Angeles, California, 2000

Ministry of Health, Dubai General Hospital, UAE, 2006

International Organizations

Member of the International Faculty for the European Masters in Nephrology, Napoli:2000

Examiner, Royal Colleges of Physicians of the United Kingdom, 2002-

Host Examiner for Egypt, Federation of the Royal Colleges of the United Kingdom, 2003--

International Advisor, Royal College of Physicians of London, 2003--

Chairman, Board of Examiners, MRCP Cairo, 2004-2009


Public Health Appointments: Member of the Egyptian Health Commission for Renal Disease: 1982 - 1988.

Member of the State Council for the Control of Medical Equipment, Ministry of Health, Egypt: 1985 - 1989.

Member of the State Council for Drug Administration, Ministry of Health, Egypt: Internal Medicine 1986 - 1993;

Renal Disease 1995-2003.

Member of the Egyptian Supreme National Commission for Kidney Diseases, 1997-2004

Chairman, National Commission for Drug Control, Kidney diseases, 2007--

Clinical Assignments: Chief of Nephrology, Al-Salam Hospital, Mohandeseen: 1982 - 2000

Councilor and Chief of Nephrology, King Fahd's Nephro-Urology Center, Cairo University: 1987 - 1999; Unit Director

1999 - 2001

Chairman of The Cairo Kidney Center: 1988 -

Former Senior Consultant in Internal Medicine & Nephrology at the Coptic Hospital, University Students' Hospital,

Maadi Military Base Hospital, Al-Salam Mohandesseen and Dar-El-Fouad Hospitals, Cairo.

Activities in Scientific Associations:

International Society of Nephrology

President of the ISN African Kidney and Electrolytes Conference, Cairo: February 198

Councilor (1993 -1999)

Member of the Management Committee (1995-1999).

Member of the Nominating Committee (1992-1995; 1995-1997; 1999-2001).

Co-chairman of the Subcommittee for Africa, a division of the Commission for the Global Advancement of

Nephrology [COMGAN] (1993-1999).

Secretary-General of the Society (1999-2005)

Director, Fellowship Program (1999-2005)

Chairman, Advisory Committee on Tropical Nephrology (2001- 2003)

Chairman, Publications Committee (2002-2005)


Chairman, Website Editorial Board (2002-2004)

Chairman, Guidelines Committee (2004-2007)

Chairman, Governance Committee (2005-2006)

Director, Renal Sister Center Program (2005-2009)

Chairman, Nominating Committee (2009-2011)

International Society for Artificial Organs (ISAO)

Regional Officer for Africa (1988-1999)

Member of the Publications Committee (1990-1996)

Vice-president of the Society (1990-1999)

International Society for Hemodialysis [ISHD]:

Council member (2001- )

Kidney Disease: Improvement of Global Outcomes initiative (KD:IGO)

Member of the International Board (2002-2007)

Member of the Executive Committee (2003- 2005)

Member of the Board of Directors (2004-2005)

Chairman, Committee for Implementation in Countries without CPGs (2003-2005).

Workgroup member for the development of Acute Kidney Injury guidelines

European Dialysis and Transplantation Association (EDTA)

Keyman for Egypt: (1980-1993).

Middle East Society of Organ Transplantation (MESOT)

Member of the Steering Committee (1990)

Member of the Board of Trustees (1990-1994)

Vice-president (1990-1994)


African Association of Nephrology [AFRAN]:

First and Founding President and Secretary General (1987 - 1990).

Chairman of the Nominating Committee (1993-1996)

Chairman of the African Nephronet (1997-1999)

Arab Society of Nephrology and Renal Transplantation

President (1995-1997).

Chairman of the Nominating Committee (1997-1999); member 1999-2001, 2001-2003, 2003-2005, 2005-2007)

Egyptian Society of Nephrology

Secretary-General (1981-1993).

President (1996-1999).

Other Scientific Organizations

Fellow of the Royal Society of Medicine, United Kingdom (1997-2005)

Member of the New York Academy of Science: (1992- )

Member of the American Association for the Advancement of Science: (1994 - )

Member of the Global Academy of Tropical Medicine (2004- )

Member of:

American Society of Nephrology.

European Dialysis & Transplant Association - European Renal Association.

Mediterranean Society of infectious disease.

Arab Society of Nephrology and Renal Transplantation.

Middle East Society for organ Transplantation.

Egyptian Society of Organ Transplantation.

Honorary Member of :

South African Renal Society: (1992- )

Lebanese Society of Nephrology (1998- )

Egyptian Society of Pediatric Nephrology (2000- )

President of the “Honors Committee”, Third Congress of Nephrology on the Internet, 2003

Member of the Medical Advisory Board, Baxter Extramural Grant, 2004.


Member of the Wyeth Medical Advisory Board, Amsterdam, 2005.

Social Accountability of Medical Schools Initiative

Member of the international reference group

Editorial Boards:

Founding Editor

Kidney Forum, the Official Journal of the Arab Society of Nephrology and Renal Transplantation (1997)

Subject Editor

Journal of Nephrology (1998-2003)

Associate Editor:

Lebanese Medical Journal (2000--)

American Journal of Kidney Diseases (2004--)

Journal of Advanced Research (2009- )

Member of the Editorial/Advisory Boards:

Nephrology, Dialysis, Transplantation (1987-1997 )

Kidney International (1989-1999 )

African Journal of Health Sciences (1994- 2000)


Saudi Journal of Kidney Diseases and Transplantation (2000-- )

Kumar and Clark’s Text Book of Internal Medicine (2004--)

Nature Clinical Practice Nephrology (2005 -- )

World Forum, American Journal of Kidney Disease (2006--)

Reviewer:

Acta Tropica

American Journal of Kidney Diseases

Artificial Organs

Clinical Journal f the American Society of Nephrology

East Mediterranean Medical Journal

Experimental and Clinical Transplantation

Hemodialysis International

Journal of Experimental Nephrology

Journal of Nephrology

Kidney International

Nephrology, Dialysis, Transplantation

Nephrology Journal

Nephron

Pediatric Nephrology

Saudi Journal of Kidney Diseases

Publications: Dissertation:

“Kinetic and clinical studies on the reuse of Kolff Twin Coil Dialyzers”. Accepted with distinction and published by

Cairo University, 1964.

Book Editor/ Co-editor:

Highlights of Kidney Diseases (1995, 2007) [Arabic] Al-Ahram Press.


Kidney diseases in the developing world and ethnic minorities (2005). Ed: El-Nahas AM, Barsoum RS, Dirks J,

Remuzzi G. London: Taylor & Francis.

Chapter Author:

Schistosomiasis In Oxford Text-Book of Clinical Nephrology (1992, 1998, 2005, 2007). Ed A Davison, JS Cameron, JP

Grunfeld, C Ponticelli, E. Ritz, CG Winereals, CV Ypersele. Oxford University press.

Ethical problems in dialysis and transplantation: Africa In Ethical Problems in Dialysis and Transplantation (1992) Ed

I CM Kjellstrand and JB Dossetor. Kluwer Academic Publishers.

Management of Acute Renal Failure In Principles and Practice of Nephrology (1995) EdII. Jacobson, Striker, Klahr.

Mosby Year book Inc.

Dialysis In the Developing World In Replacement of Renal Function by Dialysis (1996, 2004) Ed. W Horl, K M Koch, RM

Linsay, C Ronco, J Winchester. Kluwer Academic Publishers.

Tropical Nephrology In Diseases of the Kidney (1996,1999,2002,2005) Ed RW Schrier and CW Gottschalk. Little, Brown

and co.

Renal Involvement In Tropical Diseases” In Schrier's Atlas of Diseases of the Kidney (1998)

Parasitic Nephropathy” In Renal Pathology Ed. E Friedman, AMV Miles, C-K Chen. Teaching slides series (1998).

Glomerulonephritis and Infection In Comprehensive Clinical Nephrology (2000, 2003,2007,2009) Ed. R Johnson and J

Feehally. Mosby pub .

Urinary Schistosomasis In Comprehensive Clinical Nephrology (2000, 2003,2007,2009) Ed. R Johnson and J Feehally.

Mosby pub .

The Kidney in Tropical Infections” In Mechanisms and Clinical Management of Chronic Renal Failure (2000). Ed. AM El-

Nahas, KG Harris, S Anderson. Oxford University press pp 373-400

The Kidney in Schistosomal Infection In Massry & Glassock's Textbook of Nephrology (2001). Ed. SG Massry and R J

Glassock. Lippincott Williams & Wilkins.

Infection-related glomerular disease. In Mc Graw-Hill Clinical Medicine Series: Nephrology (2001). Ed F Schena, AM

Davison. H Koomans, JP Grunfeld, F Valderrabano, F Van der Woude. Mc Graw-Hill Int UK ltd. 24:229-36

Treatment strategies for end-stage renal failure in developing countries.” In Optimal Treatment Strategies in End-Stage

Renal Failure (2002). Ed C Jacobs. Oxford University Press. pp 257-301


Tropical Glomerulonephritis In Glomerular Diseases (2004,2005,2007). Ed. M Nour-El-Hoda. Al Nadwah publishers, Dubai.

Tropical Acute Renal Failure In Tropical Surgery (2004) Ed. R. Kamel and J Lumely . Westminister Publishing ltd, London

Tropical Acute Renal Failure In Sepsis, Kidney and multiple Organ Dysfunction (2004). Ed. C Ronco, R Bellomo, A

Brendolan. Contributions to Nephrology (144) Karger pub. pp 44-52.

Tropical Infections Causing Kidney Failure In Critical Care Nephrology (2007). Ed II Claudio Ronco, Rinaldo Bellomo,

and John Kellum. Elsevier.

Hepatitis C and the Kidney In Glomerular Diseases (2007). Ed. M Nour-El-Hoda. Al Nadwah publishers, Dubai.

Tropical infections and Acute Kidney Injury In Management of acute Kidney Problems (2007) Ed. C Ronco, J Kellum, A

Jorres.

Schistosomiasis. In Oxford Desk Reference In Nephrology (2009). Ed J Barratt, K Harris, P Topham. Oxford University

Press, New York.

Unique Aspects of CKD in the Developing Countries In Chronic Kideny Disease: A practical Guide to Understanding

and Management (2009) In press

Journals Guest Editor:

End-stage Renal Disease in the Developing World. Artificial Organs, (Sept. 2002).

Reviews:

RS Barsoum. Schistosomal glomerulopathy: selection factors. Nephrol Dial Transplant. 1987;2(6):488-97.

RS Barsoum. Drug interactions with Cyclosporin a: In recent aspects of the use of cyclosporin in renal transplantation. Excerpta Medica,

Amsterdam, 1987;114-121.

A Hassaballa, R Barsoum, M Soliman, E Elghoneimy, O Elkhashab, M Abouzeid, S Abouraya. Experience with Cyclosporin in renal transplantation:

In recent aspects of the use of Cyclosporin in renal transplantation. Excerpta Medica, Amsterdam, 1987; 39-45.

RS Barsoum. Parasitic nephropathies. Medical Forum 1990; 35: 19-23.

RS Barsoum. Nephrology and African ecology: An overview. Artificial Organs 1991; 14:235-237.

RS Barsoum. Inequity and dysequilibrium of dialysis in Egypt. Proceedings of the 1st International Congress of Geographical Nephrology,

Singapore, 1991.


RS Barsoum. Schistosomal glomerulopathies. Kidney Int. 1993 ;44(1):1-12.

RS Barsoum. Renal transplantation in a developing country: the Egyptian 17 year experience. Afr J Health Sci. 1994;1(1):30-36.

RS Barsoum. Africa and medical technology. Afr J Health Sci. 1994 ;1(4):138-141.

RS Barsoum. Urinary schistosomiasis. Nephrol Dial Transplant. 1995;10(6):904-6.

RS Barsoum. Nephrology in Egypt: A forecast of the forthcoming century. J Egypt Soc Nephrol 1997; 1(1):1-4.

RS Barsoum. Urinary schistosomiasis. Am J Kidney Dis. 1998 ;32(4):xliii-xlvi.

RS Barsoum. Malarial nephropathies. Nephrol Dial Transplant. 1998 ;13(6):1588-97.

RS Barsoum. Hemodialysis: Cost-conscious end-stage renal failure management. Nephrology 1998;4:S96-100.

RS Barsoum. Tropical parasitic nephropathies. Nephrol Dial Transplant. 1999;14 Suppl 3:79-91.

RS Barsoum. Malarial acute renal failure. J Am Soc Nephrol. 2000 ;11(11):2147-54.

R Barsoum, MA Bakr. The Egyptian renal transplant experience. Clin Transpl. 2000;:359-60.

Barsoum RS. Pathogenesis of Diabetic Nephropathy. (Part 1) Kidney Forum 2001; 2(11): 11-22.

Barsoum RS. Pathogenesis of Diabetic Nephropathy. (Part 2) Kidney Forum 2001; 2(2): 3-15.

RS Barsoum. End-stage renal disease in the developing world. Artif Organs. 2002 ;26(9):735-6.

RS Barsoum. Schistosomal glomerulopathy. Third Nephrology Congress on Internet, 2003 (http://www.uninet.edu/cin2003/index.en.html)

RS Barsoum. Schistosomiasis and the kidney. Semin Nephrol. 2003 ;23(1):34-41.

RS Barsoum. End-stage renal disease in North Africa. Kidney Int Suppl. 2003 ;(83):S111-4.

RS Barsoum. The changing face of schistosomal glomerulopathy. Kidney Int. 2004;66(6):2472-84.

RS Barsoum. Tropical acute renal failure. Contrib Nephrol. 2004;144:44-52.

RS Barsoum. Parasitic infections in organ transplantation. Exp Clin Transplant. 2004 Dec;2(2):258-67.

RS Barsoum Chronic kidney disease in the Developing World New Engl J Med 2006:354:997-9

RS Barsoum. Parasitic infections in transplant recipients Nature CP Nephrology 2006:2, 490-503

RS Barsoum. Hepatitis C Virus : from Entry to Renal Injury Nephrol, Dial, Transplant 2007;22(7):1840-8. Epub 2007 May 3.

RS Barsoum. Trends in unrelated-donor kidney transplantation in the developing world. Pediatric Nephrology 2008; 23(11): 1925-9.

Original Articles

Schistosomiasis S Bassily, Z Farid, RS Barsoum, LA Soliman, GI Higashi, WF Miner.Renal biopsy in

Schistosoma-Salmonella associated nephrotic syndrome.J Trop Med Hyg.

1976 ;79(11):256-8.

RS Barsoum, S Bassily, OK Baligh, M Eissa, N El-Sheemy, N Affify, AM Hassaballa.Renal

disease in hepatosplenic schistosomiasis: a clinicopathological study.Trans R Soc

Trop Med Hyg. 1977;71(5):387-91.

RS Barsoum, S Bassily, M Soliman, M Milad, AM Hassaballa. Amyloidosis in hepatosplenic


schistosomiasis.Trans R Soc Trop Med Hyg. 1978;72(2):215-6.

RS Barsoum, S Bassily, MM Soliman, MF Ramzy, M Milad, AM Hassaballa. Renal

amyloidosis and schistosomiasis.Trans R Soc Trop Med Hyg. 1979;73(4):367-74.

RS Barsoum, M Kamel, N Bakir, E Elghoneimy, M Soliman, O El-khashab, M Abouzeid, A

Hassaballa. Some immunological aspects in schistosomal

nephropathy.Proceedings of the 2nd conference of the Egyptian Society of

Nephrology, Cairo, 1982.

RS Barsoum, S Gemei, M Zaatar, E Elghoneimy, M Soliman, O Elkhashab, M Abouzeid, A

Hassaballa.OKT subsets in schistosomal nephropathy.Proceedings of the 5th

conference of the Egyptian Society of Nephrology, Cairo, 1985.

R Barsoum, S Gemei, S Abdel Latif, E El-ghoneimy, M Soliman, O Elkhashab, MH

Abouzeid, A Hassaballa.OKT subsets in bilharzial hepatic fibrosis.Proceedings of the

5th conference of the Egyptian Society of Nephrology, Cairo, 1985.

RS Barsoum, G Sersawy, S Haddad, MB Hashem, M Kamel, N Wassef, M Francis, E

Ghonaimy, M Soliman, O Khashab, et al. Hepatic macrophage function in

schistosomal glomerulopathy. Nephrol Dial Transplant. 1988;3(5):612-6.

M Abouzeid, A El-Kaliouby, A Soliman, M Nabil, M Kamel, R Barsoum. Renal sodium

handling and influence of tubular sodium manipulation in endemic

hepatosplenomegaly with and without ascites. J Egypt Med Assoc. 1989;72:525-

536.

RS Barsoum. Schistosomal glomerulopathy (SG). High time for a classification.

Proceedings of the 11th International Congress of Nephrology, Tokyo, Japan, 1990.

RS Barsoum. Recurrent haematuria in Schistosoma infection. Pediatr Nephrol.

1990 ;4(3):252.

MH Hafez, M Zaatar, MH Abouzeid, M Kamel RS Barsoum. HLA A1, B35, DR 1,4 and

hephrotic syndrome in adult Egyptians. Med J Cairo Univ 1991;59(4):947-956.

A Amin, M Francis, A Zakareya, A Elkalio By, A Elgarem , R Barsoum. Microalbminuria:

an early indicator of glomerular involvement in hepatosplenic schistosomiasis.

Proceedings of the 2nd international Congress of Geographical Nephrology,

Hurghada, 1993.

I Nessim, M Francis, H Abdel-Rahman, O El-Rouby, R Barsoum. Tubular protiens(TP) in

hepatosplenic schistosomiasis (HSS). Proceedings of the 2nd international Congress

of Geographical Nephrology, Hurghada, 1993.

G Saadi, M Nabil, C Genin, M Francis, I Iskander, A Elgarem, R Barsoum.

Immunoglobulin pattern in schistosomal glomerulopathy (SG)- the significance of

IgA. Proceedings of the 2nd international Congress of Geographical Nephrology,

Hurghada, 1993.


HM Abdel-Rahman, L Nessim, M Francis, OA El-Rouby, R Barsoum. Immune-mediated

tubulopathy in patients with schistosomal hepatic fibrosis. Egypt. J. Bilh. 1994;

16,1,2:17-35.

RS Barsoum, M Nabil, G Saady, C Genin, E Saleh, M Francis, A El-Kalioubi, I Iskander, A

El-Garem. Immunoglobulin-A and the pathogenesis of schistosomal

glomerulopathy.Kidney Int. 1996 ;50(3):920-8.

Clinical Nephrology RS Barsoum, M Milad, MH Shaheen. Hereditary nephritis. J Egypt Med Assoc. 1977;60(7-8):567-9.

RS Barsoum, MH Shaheen, MM Soliman, N El-Sheemy, M Milad, A Hassaballa. Lupus nephritis. J Egypt Med Assoc. 1977;60(5-6):363-83.

R Barsoum, N Afify, O Gohar, T Fahmy. Circulating immune complexes in acute glomerulonephritis. Possible clinical implications of the different

tests used in their in-vitro detection. J Egypt Med Assoc. 1978;61(6):215-223

R Barsoum, W Rafla, H Samra, A Wahba, H Elgammal, A Hassaballa. Hyperuricaemia in accelerated hypertension a marker of tissue hypoxia.

Proceedings of the 20th Congress of the European Dialysis and Transplant Association, Vienna, 1983.

M Abouzeid, M Soliman, O Elkhashab, R Barsoum, H Elghoneimy, N Aabed, A Hassaballa, M Kamel, S Gemei. Platelet aggregation in nephrotic

patients. Med J Cairo University 1984; 52(1): 21-27.

M Abouzeid, O Elkhashab, M Soliman, R Barsoum, E Elghoneimy, A Elashry, A Hassaballa, M Kamel. Lymphocytic transformation in nephrotic

patients. J Egypt Med Assoc. 1984; 67(2): 93-104.

O Elkhashab, M Abouzeid, R Barsoum, E Elghoneimy, M Soliman, M Mahgoub, A Hassaballa, N Hassaballa. Effect of captopril on blood flow in

intestinal blood vessels. Med J Cairo University 1986; 54( 3): 398-402.

R Barsoum, R Sharoubim, M Milad, M Francis, E Elghoneimy, M Soliman, O Elkhashab, M Abouzeid, A Hassaballa. Proliferative glomerulonephritis

(PGN): experience of an Egyptian specialized nephrology center. Kidney Int 1987;32:608.

M. Abouzeid, O El-Khashab, R Barsoum, E Elghoneimy, M Soliman, M Radwan, A Hassaballa, S El-Kateb. Serum reverse tri-iodothyronine in

nephrotic patients. Med J Cairo University 1987; 55(5): 525-540.

M Abouzeid, M Kamel, M Zaatar, A Soliman R Barsoum. HLA genes and endemic viral infections in nephrotic children in Egypt. Proceedings of

the First Pan Arab Congress of Nephrology and Renal Transplantation, Amman, Jordan,1988.

M Asaad, I Iskander, M Francis, M Radwan R Barsoum. Essential mixed cryoglobulinaemia. Report on 10 consecutive cases. Proceedings of the

8th Congress of the Egyptian Society of Nephrology, Mansoura, Egypt, 1989.

R Barsoum, M Francis. RHP-associated renal amyloidosis. A single centre 5-years experience. Proceedings of the First Recurrent Hereditary

Polyserositis (RHP), Amman, Jordan, 1990.

M Tadros, M Fillobos, I Iskander, R Barsoum. Hypercalciuria in recurrent nephro- lithiasis. Experience of a specialized stone clinic. Proceedings of

the Second Pan Arab Congress of Nephrology and Renal Transplantation, Cairo, Egypt,1990.

Philibos, M., Francis, M., Barsoum, R. Patterns of primary glomerulonephritis in the poooled experience of a specialized kidney center.

Proceedings of the 11th Congress of the Egyptian Society of Nephrology, Cairo, Egypt, 1992.

RS Barsoum, M Galal, R Faltas, M Shokry. The short term synergistic effect of combined Cyclosporine-A and Captopril in the treatment of classical

FSGS. Proceedings of the 4th Pan Arab Congress of Nephrology and Renal Transplantation, Tunis, Tunisia,1994.


H Yassa, T Fayad, M Chaker, R Barsoum. Case report: Laurence Moon Biedle syndrome with Type I renal tubular acidosis. Proceedings of the First

Pan-Arab Congress of Pediatric Nephrology, Cairo, 1996.

Diabetes and the Kidney R Barsoum, A Hassanein, M Milad, M Shaheen. Platelet aggregation and disaggregation in diabetic nephropathy. J Egypt Med Assoc.

1975;58:249-269.

R Barsoum, M milad, H Elghoneimy, H Mowafy, N El-Sheimy, A El-Badry. Nephrotic syndrome as the initial presentation of diabetic nephropathy. J

Egypt Med Assoc. 1975;58:361-370.

El-Badry A, Hassaballah AM, El-Ayadi A, Barsoum RS, Shaheen MH, El-Ghoneimy EH, Abdel-Rahman Y, El-Bagoury I. Plasma immuno-reactive

insulin (IRI) and peripheral glucose utilization in bilharzial patients with impaired renal functions. J Egypt Med Assoc. 1975;58(7-8):361-9.

R Barsoum, a hassanein, M milad, M Shaheen. Platelet aggregation and disaggregation in diabetic nephropathy. J Egypt Med Assoc. 1975;58(5-

6):249-69.

El-Badry A, El-Ayadi A, Hassaballah AM, Barsoum RS, Shaheen MH, Abdel-Rahman MY, El-Bagoury I, Ibrahim Z. Plasma immunoreactive insulin

(IRI) and glucose tolerance in bilharzial hepatic fibrosis. J Egypt Med Assoc. 1976;59(1-2):5-22.

E Elghoneimy, N Hassaballa, R Barsoum, M Soliman, O Elkhashab, M Abouzeid, A Hassaballa. Effect of continuous insulin infusion on renal tubular

sodium transport in man using the artificial endocrine pancreas. Medical J Cairo University 1984; 52(3): 401-408.

E Elghoneimy, N Hassaballa, R Barsoum, O Elkhashab, M Soliman, M Abouzeid, A Hassaballa. Blood glucose normalization by intensified/pump

insulin therapy. Proceedings of the First ISN African Kidney and Electrolytes Conference, Cairo, 1987.

Sheta M, Barsoum RS, Abouzeid MH, El-Hamamsy M, Tadros G, Kamel M. Hypertension, Impaired glucose tolerance and insulin resistance.

Medical J Cairo University 1992; 60:

Acute Renal Falure A Elbadry, AM Hassaballa, A Ayady, AM Saadany, R Barsoum. Diagnostic procedures in acute obstructive nephropathies.Med J Cairo University

1967;35:267-310.

A Elbadry, AM Hassaballa, A Ayady, R Barsoum.Clinical and biochemical aspects of acute renal failure. Analysis of 151 cases.Med J Cairo

University 1967; 35: 265-286.

AM Hassaballa, A Ayady, MH Shaheen, R Barsoum, A Elbadry, H Eissa, F Metkees.On the diagnosis and management of bacteraemic

shock.Med J Cairo University 1971; 39:

A Fam a, RS Barsoum. Diuresis and prostatectomy. Int Surg. 1971; 56(3):187-92.

R Barsoum, Z Rihan, O Baligh, A Hozayen,E Elghoneimy, M Ramzy, T Elgarf, A Ibrahim. Post-traumatic jaundice. Experience with 1279 battle

casualties in 1973 Middle-East war. J Egypt Med Assoc. 1974;57:9-16.


R Barsoum, M Shaheen, M Soliman, N Elsheimy, M Milad, AM Hassaballa. Acute renal failure in the 6th October war. Experience of a specialized

base hospital. Prognostic factors. J Egypt Med Assoc. 1974;57:

M Khafagy, MN el-Bolkainy, RS Barsoum, S el-Tatawy. The ileocecal bladder: A new method for urinary diversion after radical cystectomy (a

preliminary report). J Urol. 1975;113(3):314-6.

M Shaheen, N Afify, N Elsheimy, N Elayady, R Barsoum. Immunoglobulin kappa light-chains in acute renal failure. Egyptian J Hematol 1978; 3: 19.

RS Barsoum, ZE Rihan, OK Baligh, A Hozayen, EH El-Ghoneimi, MF Ramzy, AS Ibrahuim. Acute renal failure in the 1973 Middle East war--experience

of a specialized base hospital: effect of the site of injury. J Trauma. 1980 ;20(4):303-7.

M Soliman, N Elsheimy, R Barsoum, E Elghoneimy, O Elkhashab, M Abouzeid, A Hasaballa. Effect of high dose urography (HDU) & renal function,

serum & urinary b2 microglobulin (b2m) in CRF.J Egypt Med Assoc. 1983; 66(6):681-692.

A Hassaballa, M Razak, A Amin, S Saleh, R Barsoum, E Elghoneimy, M Soliman, N Hassaballa, M Abouzeid. Renal histopathological and functional

studies in obstructive jaundice. J Egypt Med Assoc. 1984;67:`93-206.

MG El-Saady, IA Soliman, NA Abulatta, H Abdel-Rahman, A Atta, H Soliman, R Barsoum. Sort-term effect of the cervical lymphovenous (CLVS)

shunt on renal sodium handling in patients with ascites due to hepatosplenic schistosomiasis (HSS).Proceedings of the 4th Congress of the

Arab Society of Nephrology and Renal Transplantation, Tunis, Tunisia,1995.

Chronic renal Failure M Abd Elkader, Mt Abdel Aziz, Am Hassaballa, M Shaheen, R Barsoum, O Elkhashab. Neuro-pituitary-adrenal axis in chronic renal failure. Egypt J

Physiol, 1976;16:34-43.

Shahin Mh, Afifi N, El Sheemy N, Mohamed Aa, Barsoum Rs. On the mechanism of cell-mediated immunodeficiency in chronic renal failure. J

Egypt Med Assoc. 1977;60(5-6):385-95.

R Barsoum, N Abou El Fetouh, O Elkhashab H Mowafy, Am Hassaballa. Steroids and indomethacin in uraemic pericarditis. A prospective

controlled, double-blind trial. J Egypt Med Assoc. 1979;62 45-62.

R Barsoum, O Elkhashab, M Faisal, E Elghoneimy, M Soliman, H Mowafy, M Abouzeid, A Hassaballa. Taste sensation in chronic renal failure.

Proceedings of the 8th International Congress of Nephrology, Athens, Greece,1981.

O Elkhashab, M Kamel, G Saadi, R Barsoum E Elghoneimy, M Soliman, H Mowafy, M Helmy, A Hassaballa. Neutrophil chemotaxis in chronic renal

failure. Proceedings of the 8th International Congress of Nephrology, Athens, Greece,1981.

M Soliman, O Elkhashab, H Abouzeid, R Barsoum, E Elghoneimy, M Ramzy, A Hassaballa, M Elkhodary. Alteration of serum enzymes in chronic

renal failure. J Egypt Med Assoc. 1984; 67, suppl. 2: 39-48.

O Elkhashab, M Soliman, M Abouzeid, R Barsoum, E Elghoneimy, M Hafez A Hassaballa. Autonomic cardiovascular neuropathy in chronic renal

patients. J Egypt Med Assoc. 1984; 67: 119-130.

El Ghonaimy E, Barsoum R, Soliman M, El Fikky A, Rashwan S, El Rouby O, Haddad S, El Khashab O, Abou Zeid M, Hassaballah N, et al. Serum

gastrin in chronic renal failure: morphological and physiological correlations. Nephron. 1985;39(2):86-94.

E Elghoneimy, S Shoheib, R Barsoum, M Soliman, O Elkhashab, M Abouzeid, N Hassaballa, A Hassaballa. Gastric flora and gastric empyting in

cases with chronic renal failure. Proceedings of the First ISN African Kidney and Electrolytes Conference, Cairo, 1987.


E El-Ghoneimy, R Barsoum, M Soliman, O Elkhashab, M Abouzeid, A Hassaballa, Ir Iskandar. T-lymphocyte subsets in uraemics complicated with

tuberculous infections (TB). Proceedings of the First ISN African Kidney and Electrolytes Conference, Cairo, 1987.

M Shenouda, M El-Zein, M Sharaf-El-Din, I El-Esper, F Boitte, A Fournier, R Barsoum. Cirrhosis ameliorates renal osteodystrophy (ROD) in patients on

regular hemodialysis (RHD). Proceedings of the 41st Congress of the European Dialysis and Transplant Association, Lisbon, Portugal, 2004.

Dialysis, Hemofiltration, Plasmapheresis AM Hassaballa, A Ayady, Mh Shaheen, R Barsoum, A Elbadry. Sodium and urea diffusion patterns in fresh versus reused Kolff coil dialysis. Med J

Cairo University 1967; 35: 769-797.

AM Hassaballa, A Ayady, Mh Shaheen, R Barsoum, A Elbadry. Biological sodium-urea inter-relations with fresh and reused Kolff coils dialysis. Ain

Shams Med J 1974; 25: 463-474.

R Barsoum, AM Hassaballa, A Ayady, A Elbadry. Blood flow patterns in reused Kolff coils. Med J Cairo University 1974; 42: 191-196.

AM Hassaballah, A Ayadi, MH Shaheen, RS Barsoum, A el-Badry. Post-dialysis urea rebound. J Egypt Med Assoc. 1974;57(5-6):215-26.

E Elghoneimy, O Elkhashab, R Barsoum, M Soliman, M Radwan, A Hassaballa, M Kamel. Hepatitis-B infection in chronic haemodialysis patients. J

Egypt Med Assoc. 1980;63:33-40.

M Soliman, M Kamel, R Barsoum, E Elghoneimy, O Elkhashab, M Abouzeid, A Hassaballa. Effect of dialyser re-use on neutrophil chemotaxis.

Proceedings of the 8th International Congress of Nephrology, Athens, Greece, 1981.

M Soliman, E Elkhodary, A Roushdy, R Barsoum, E Elghoneimy, O Elkhashab, M Abou-Zeid, A Hassaballa. Serum LDH5 (heat labile) in

haemodialysis patients. An unexpected rise of LDH5 in patients with ischaemic heart disease. Proceedings of the 8th International Congress

of Nephrology, Athens, Greece, 1981.

M Soliman, A Soliman, M Elkhodary, R Barsoum, E Elghoneimy, O Elkhashab, M Abou-Zeid, A Hassaballa. Cardiac complications in haemodialysis

patients. Proceedngs of the 7th Saudi Medical Meeting, Dammam, KSA, 1982.

M Soliman, M Abouzeid, O Elkhashab, G Elsirsawy, R Barsoum, E Elghoneimy, A Hassaballa, F Halawa, A Abd Elhafeiz. Serum reverse T3 (rT3) in

chronic renal failure and haemodialysis patients. Proceedngs of the 8th Saudi Medical Meeting Riyadh, KSA, 1983.

M Soliman, O Elkhashab, M Abouzeid, R Barsoum, E Elghoneimy, G Tadros, A Hassaballa. Protein bound hexose (PBH) in CRF and dialysis patients.

J Egypt Med Assoc. 1983; 66: 693-704.

M Soliman, R Barsoum, E Elghoneimy, O Elkhashab, M Abouzeid, A Hassaballa, O Gohar. Effect of dialyser re-use on platelet aggregation (PA). J

Egypt Med Assoc. 1984; ; 67: 193-206.

M Soliman, M Ibrahim, O Elkhashab, M Abouzeid, A Soliman, R Barsoum, E Elghoneimy, A Hassaballa. Echocardiographic assessment of left

ventricular function (LVF) in haemodialysis patients. Med J Cairo University 1984; 52(3): 409-421.

M Abouzeid, M Soliman, O Elkhashab, R Barsoum, H Elghoneimy, N Aabed, A Hassaballa, M Kamel, S Sobhy. Cellular immunity in intermittent

peritoneal and haemodialysis patients. Med J Cairo University 1984; 67: Supp 2: 49-58.

R Barsoum, A Shams El Din, T Eyada, E Elghoneimy, M Soliman, O Elkhashab, M Abouzeid, A Hassaballa. Effect of dialysis on red cell ATP in

chronic renal failure. Proceedings of the 8th International Congress of Nephrology, Los Angeles, USA, 1984.

R Barsoum, M Kamel, M Radwan, E Elghoneimy, M Soliman, O Elkhashab, M Abouzeid, A Hassaballa. Concomitant association of Hepatitis Bs

antigen & anti-HBs antibody in regular hemodialysis patients. Proceedings of the 4th International Congress of Mediterranean Countries for

Chemotherapy, Rome, Italy, 1984


M Soliman, A Soliman, M Ibrahim, R Barsoum, H Elghoneimy, O Elkhashab, M Abouzeid, A Hassaballa. Effect of correction of dialysis-induced

hypoxemia and hypovolaemia on left ventricular function (LVF). Proceedings of the 8th International Congress of Nephrology, Los Angeles,

USA, 1984.

M Abouzeid, E Elghoneimy, G Saad, R Barsoum, M Soliman, D Elkhashab, M Baghat, F Halawa, A Hassaballa. The effect of bicarbonate dialysis

on lactate/pyruvate ratio after minimal exercise in regular dialysis patients. Med J Cairo University 1985; ; 53(6), 607-616.

O Elkhashab, M Abouzeid, R Barsoum, E Elghoneimy, M Soliman, G Saadi, A Hassaballa, N Hassaballa. Effect of dialyzer reuse on dialysis induced

hypoxia. Med J Cairo University 1986; ; 54(2):209-216.

O Elkhashab, M Abouzeid, R Barsoum, E Elghoneimy, M Soliman, A Hassaballa, G Saadi, N Hassaballa. Dialysis-induced hypoxia: pathogenesis

and the effect of various dialysis techniques. Med J Cairo University 1986; 54(2)253-266.

R Barsoum, M Ramzy, M Francis, B Abdulla. Egyptian CAPD experience. Proceedings of the 23rd European Dialysis and Transplant Association

meeting, Budapest, Hungary, 1986.

M Radwan, R Barsoum, E Elghoneimy, M Soliman, O Khashab, M Abouzeid, A Hassaballa. Persistent improvement of proteinuria in MCGN with

normal renal function following plasma exchange. Plasma therapy 1986;7(3);412.

M Radwan, R Hamza, R Barsoum, O Elkhashab, M Abouzeid, M Kamel, M Francis. Improved prognosis in multiple myeloma with renal failure

following plasma exchange. Proceedings of the First ISN African Kidney and Electrolytes Conference, Cairo, 1987.

M Radwan, R Barsoum, O Elkhashab, M Abouzeid, A Roushdy, M Francis, M Kamel. Renal amyloidosis treated by plasmapheresis. Report of a

case. Proceedings of the First ISN African Kidney and Electrolytes Conference, Cairo, 1987.

O Elkhashab, M Abouzeid, R Barsoum, E Elghoneimy, M Soliman, M Radwan, T Osman, A Hassaballa, S Gomeiy. T-lymphocyte subtypes in

chronic renal failure patients on regular haemo- and peritoneal dialysis. Med J Cairo University 1987; 55(4): 557-564.

E Elghoneimy, J Metry, M Francis, M Eshmawy, R Barsoum, A Hassaballa. Results of regular dialysis treatment in an elderly population. Kidney Int

1987; ; 32: 607.

N Chafik, M Sobara, R Barsoum. Effect of mannitol 20% and normal saline in alleviating dialysis-induced hypotension. Proceedings of the First ISN

African Kidney and Electrolytes Conference, Cairo, 1987.

M Radwan, R Barsoum, O Elkhashab, M Abouzeid, M Kamel. Nylon filters obstruction during plasma exchange using the haemonectics RV50 cell

seperator. Proceedings of the First ISN African Kidney and Electrolytes Conference, Cairo, 1987.

M Radwan, A Soliman, M Saadi, U Sharaf-El-Din, M Abouzeid, R Barsoum. Effect of dialyzer re-use on potassium kinetics during haemodialysis.

Med J Cairo University 1989; 57:

A Filobbos, R Faltas, M Barsoum, R Barsoum.Retroperitoneal haemorrhage (RPH): a rare but potentially fatal complication of femoral

catheterization for haemodialysis. Proceedings of the 2nd Pan Arab Congress of Nephrology and Renal Transplantation, Cairo, Egypt,1990.

MG Saady, MH Hafez, AS Saiid, AM Kenawi, MM Radwan, O El-Khashab, RS Barsoum. Risks of subclavian vein cathetrerization as a vascular

access for hemodialysis. Med J Cairo Univ 1992; 60(3) supp:161-167.

HS Riad, H Samuel, I Iskander, M De Broe, R Barsoum. The dialysis concentrate as a source of aluminum intoxication in renal dialysis-treated

patients. Proceedings of the 11th Congress of the Egyptian Society of Nephrology, Cairo, Egypt, 1992.

H Riad, M Zaki, T El-Demerdash, I Iskand Er, M De Broe, R Barsoum. Aluminum(Al) overload impairs neutrophil phagocytosis (NPH) in patients with

chron ic renal failure (CRF) on regular haemodialysis. Proceedings of the 2nd international Congress of Geographical Nephrology, Hurghada,

1993.


PC Haese, MM Couttenye, WG Goodman E Lemoniatou, P Digenis, I Sotornik, A Fagalde, R Barsoum, LV Lamberts, M De Broe. Use of low-dose

desferroxamine test to diagnose the differentiate between patients with aluminum-related bone disease. Nephrol Dial Transplant

1995;10:1874-1884.

J William, N Saad, M Salib, H Riad, KS Mahran, I Iskander, G Cozma, R Barsoum. The acute effect of intravenously administered recombinant

human erythropoietin on the immune response of uremic patients maintained on regular hemodialysis. Artif Organs. 1998 ;22(3):192-6.

AH. Ali, M. El-Arini, N. Tadros, M. Fouad, N. Atalla, M. Tawfik, R. Barsoum. Depression as a mortality risk factor in dialysis (DMRD Study). Phase 1:

Methodology and screening. Proceedings of the 222nd Congress of the Egyptian Society of Nephrology, Sharm El-Sheikh, 2003.

N. Atalla, N. Barsoum, M. Fouad, M. El-Arini, AH. Ali, R. Barsoum. Duplex Doppler ultrasonography as a tool for online measurement of blood-flow

rate in haemodialysis. Proceedings of the 222nd Congress of the Egyptian Society of Nephrology, Sharm El-Sheikh, 2003.

FA Arogundade, B Zayed, M Daba, RS Barsoum. Correlation between Karnofsky Performance Status Scale and Short-Form Health Survey in

patients on maintenance hemodialysis. J Natl Med Assoc. 2004 Dec;96(12):1661-7.

F Arogundade, RS Barsoum. Indices for assessment of hemodialysis adequacy: a comparison of different formulae. Hemodial Int. 2005 ;9(4):325-

31.

O Abboud, R Barsoum, F Berthoux, et al. European Best Practice Guidelines for Peritoneal Dialysis acknowledged by ISN. Nature Clin Pract

Nephrol. 2007;3(1):6-7

Transplantation A Hassaballa, R Barsoum, M Soliman, M Kamel, M Safwat, H Torky, I Shokry, A Kotb, A Hamman. First year experience with renal transplantation.

Proceedings of the 7th International Congress of Nephrology, Montreal, Canada, 1978.

R Barsoum, A Ibrahim, Z Rihan, A Lebstein. Renal transplantation. A knowledge, attitude, and practice (KAP) study. I. Study design & opinion of

leading groups.Armed Forces Med J 1979; 21: 97-119.

RS Barsoum, M Kamel, El- O Khachab, Am Hassaballa, M Safwat. Successful renal transplantation in a presensitized recipient after multiple blood

transfusions. Clin Nephrol. 1980 ;14(1):45-8.

R Barsoum, M Kamel, O Elkhashab, E Elghoneimy, M Soliman, M Abouzeid, A Hassaballa, M Safwat. Prospective multiple blood transfusions in

presensitised potential transplant recipients. Proceedings of the 11th International Congress of Nephrology, Athens, Greece, 1981.

R Barsoum, H Torki, E Elghoneimy, I Shokry, A Kotb, M Kamel, M Soliman, A Nasef, O Elkhashab, M Abouzeid, S Hamam, A Hassaballa, M Safwat.

Multi-center experience in live unrelated donor transplantation in Egypt. Proceedings of the First Algerian Congress of Nephrology 1985.

R Barsoum, A Hassan, A Bedeir, H Hafez, H Gobran, & I Iskander. Monitoring of haemoglobin s (HBs) in kidney transplantation for sickle cell

disease (SCD). Nephrol Dial Transp 1989; 4: 600-601.

M Saadi, A Hassan, M Asaad, M Tawfik, R Barsoum. Salmonella-associated rejection in renal transplant recipients. Proceedings of the 11th

International Congress of Nephrology, Tokyo, Japan, 1990.

M Tawfik, H Edward, M Francis, R Barsoum. Cystinosis: recurrence in a transplanted kidney? Proceedings of the 2nd Congress of the Middle East

Society for Organ Transplantation, Kuwait, 1990.

R Barsoum, A Hassan, M Francis, I Iskander, H Torky. The functional component of cyclosporine (CsA) nephrotoxicity: justification for further dose

reduction? Proceedings of the 2nd Congress of the Middle East Society for Organ Transplantation, Kuwait, 1990.


R Barsoum, S Abou Raya, M Kamel, M Abul Ghar, A Hassaballah. Effect of pregnancy on transplantation immunity. Proceedings of the 2nd Pan

Arab Congress of Nephrology and Renal Transplantation, Cairo, Egypt,1990.

R Barsoum, H Yassa, O El-Khashab, Mg Saady, Mh Hafez, M Kamel, I Iskander, A Hassaballah. Endemic cytomegalovirus (CMV) infection and

renal transplantation in Egypt. Med J Cairo University 1992; 60(4): 1079-1082.

Barsoum RS. The Egyptian transplant experience. Transplant Proc. 1992 Dec;24(6):2417-20.

MT Farid, H Torky And RS Barsoum. Psychological profiles in related and unrelated live kidney donors. Proceedings of the 2nd international

Congress of Geographical Nephrology, Hurghada, 1993.

RS Barsoum. De-novo immunosuppression: Balancing short and long-term clinical goals. Proceedings of the 12th Congress of the European

Society for Organ Transplantation, Geneva, 2005.

Arogundade FA, Abd-Essamie MA, Barsoum RS Health-related quality of life in emotionally related kidney transplantation: deductions from a

comparative study. Saudi J Kidney Dis Transpl. 2005 July-September;16(3):311-20.

Abou-Elela A, Morsy A, Reyad I, Torky M, Meshref A, Barsoum R. Modified extravesical ureteral reimplantation technique for kidney transplants.Int

Urol Nephrol. 2007 Jun 12; [Epub ahead of print]

Barsoum R, Morsy, A, Iskander I, Morgan M, Fayad T, Atalla, N, Wafik, Grace R, Adel, N, Khalil S. The Cairo Kidney Center Protocol for Rapamycin-

based sequential immunosuppression in Kidney transplant recipients: 2-year outcome. Exper Clin Transpl. 2007, 2:649-57.

Epidemiology RS Barsoum, ZE Rihan, AS Ibrahim, A Lebstein. Long-term intermittent haemodialysis in Egypt. Bull World Health Organ. 1974;51(6):647-54.

RS Barsoum. Ethical and moral dilemmas arising from uremia therapy in the third world - a "KAP" review. Progress in Artificial Organs 1986; 89-95.

RS Barsoum. Nephrology and Egyptian Ecology. Proceedings of the 8th Egyptian Congress of Nephrology (Fayoum, Egypt) 1988.

R Barsoum, S Shahrezad, O Abdel-Azim, A Soliman, H Yassa, M Abdel-Samei. Dialysis ward bio-ecology in a developing country. Effect on the

results of treatment & impact of socioeconomic factors. Artificial Organs 1991; 15:259.

M Abdel-Samei, A Soliman, T Fayad, R Barsoum & C Kjellstrand. Serious Renal Disease in Egypt. International Journal of Artificial Organs 1995;

18(5): 254-60.

RS Barsoum. Renal Disease in Indigenous Populations: North Africa. Nephrology 1998;4:S29-32.

RS Barsoum. African nephronet. Nephrol Dial Transplant. 1998;13 Suppl 1:86-8.

R Barsoum, M Francis. Spectrum of Glomerulonephritis in Egypt. Saudi Journal of Kidney Diseases and Transplantation 2000; 11(3):1-9.

R Barsoum, Afifi A I, Bazzal, I El-Sayed. Management of pre-end stage renal failure in Egypt. Saudi J Kidney Dis Transplant 2002;13(3):353-362.

G Eknoyan, N Lameire, R Barsoum, KU Eckardt, A Levin, N Levin, F Locatelli, A MacLeod, R Vanholder, R Walker, H Wang. The burden of kidney

disease: Improving global outcomes. Kidney Int. 2004 ;66(4):1310-4.

N Lameire, G Eknoyan, R Barsoum, KU Eckardt, A Levin, N Levin, F Locatelli, A MacLeod, R Vanholder, R Walker, H Wang. A new initiative in

nephrology: 'Kidney disease: improving global outcomes'. Contrib Nephrol. 2005;149:90-9.


Experimental SA El-Wahed, MB el-Hawary, R Helmy, A el-Ayadi, RS Barsoum. A biological method for diagnosis of different forms of arterial hypertension. J

Egypt Med Assoc. 1972;55(2):174-83.

RS Barsoum, A Aziz, M Barsoum, D Agoury, M Hassan, M Abouzeid, M Kamel, E Elghoneimy, M Soliman, O Elkhashab, A Hassaballa, Y Abdel-

Rahman, A El-Badry. EEffect of insulin on renal sodium and water handling in insulinopenic diabetics & in normal dogs. Proceedings of the JP

Merrill Memorial Symposium, Boston, USA 1985.

Biomedical Engineering RS Barsoum. A new locally constructed dialysis system. Proceedings of the First International Congress of Biomedical Engineering, Cairo, 1976.

RS Barsoum. Three-year experience with the local dialyzer. Proceedings of the Second International Congress of Biomedical Engineering, Cairo,

1979.

M Sorour, R Barsoum, Z Rihan, M Saadi. Effect of disturbances in circulatory dynamics on perpetuation and pathogenesis of renal disease. Egypt

J Biomed Eng 1980; 1: 149-152.

Organizational RS Barsoum. The ISN's Sister Renal Center program Nature Clin Pract Nephrol. 2007;3(1):1.

Autobiography RS Barsoum. My journey in and with nephrology. Saudi J Kidney Dis Transpl. 2005 ;16(3):383-96.

RS Barsoum. Am J Kidney Dis. 1998 ;32(4):xliii-xlvi.

Thesis Supervisor:

Doctorate degree: 56 theses in Internal Medicine (mainly renal), Clinical Pathology, Biochemistry, Biochemical

Engineering and Nephrological Nursing.

Masters degree: 58 theses in Internal Medicine, Clinical Pathology, Radiology Biochemistry, Biomedical


Engineering and Nursing.

Clinical Trials:

Principal investigator in international, regional and local clinical trials: Deoxyspergualin in acute transplant rejection (Nippon Kayako).

Consupren in Auto-immune disorders (Galena).

Basiliximab in Induction treatment for renal transplantation (Novartis)

Ismaferon in HCV infection in dialysis patients (Chemifarm)

Cistinol in renal free water handling (Sekem)

Myofortic in renal transplantation (Novartis)

Gum Arabic in CKD (Sekem)

Sequential Rapamycin-based immunosuppression in kidney transplantation (CKC)

Engineering: Designed and built 4 generations of a Central Dialysis System applied in 3 centers (1976-- ), documented in the

International museum for Artificial Organs, Cleveland, Ohio.

Military Service: Served as Colonel in the Egyptian Armed Forces Medical Services, Maadi Base Hospital, (1973-1974)

Public Appointment: Member of St. Mary’s Church Council, Zamalek, Cairo(1996--)

Private accomplishments: Founding member of the Board of Directors, Al-Salam Hospital, Mohandesseen, Cairo (1982-1987)

Owner and Chairman of The Cairo Kidney Center, Cairo (1987--)


Professor Dr. Adel M. Afifi

Personal:

Name: Adel Mohammed Afifi

Sex: Male

Date Of Birth: 20 December 1950

Citizenship: Egyptian

Marital Status: Married.

Native Language: Arabic

Other Languages: English, French

Address: 6 Labib El Shahed St. Heliopolis,

Cairo, Egypt, 11351

Home Tel. (202) 6390288

Clinic Tel. (202) 4534748

Mobile. (20) 0101403898

e-mail: [email protected]

Education :

• M.B.B.Ch., 1974, Faculty Of Medicine, Ain Shams University, Cairo, Egypt.

• Master Degree, Internal Medicine, 1978, Faculty Of Medicine, Ain Shams University, Cairo, Egypt.

• MD. Degree, Internal Medicine & Nephrology, 1983, Faculty Of Medicine, Ain Shams University, Cairo, Egypt.

• International Scholar, 1983, Cleveland Clinic Foundation, Ohio, USA.

Occupational Details:


Professor, Internal Medicine and Nephrology, Ain Shams University, Cairo, Egypt, 1994 till present.

Teaching experience for undergraduate and postgraduate students in internal medicine and Nephrology at Ain

Shams University since 1983 till present.

Consultant internist and nephrologist at Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia, 1990-1996.

Director, dialysis department, Ain Shams University specialized hospital (1998-1999).

President, National Kidney Foundation - Egypt (1997 - 2003).

Vice president, Egyptian Society of nephrology (1997 – 2003).

Co-Chairman, Education committee of the International Federation of Kidney Foundations (2000- 2001).

Member, executive committee board of the International Federation of Kidney Foundations (2002- 2005).

President of the Egyptian renal data registry from 1997 till present.

Vice president, middle east society of nephrology (2003- till present).

Member of the Interventional ll present.committee of nephrology (ISN) from 2003 ti

Invited Speaker

All Egyptian Society of Nephrology congresses since 1996 till present.

First International Congress Of The International Federation Of Kidney Foundations, Capadocia, Turkey, 2000.

Title: Implementation of the NKF-Egypt.

Kingdom of Oman: Think Nephrology Congress, April 2001.

Title: Guidelines for treating anemia among chronic renal failure patients.

Second International Congress Of The International Federation Of Kidney Foundations, Los Angeles, California, USA, ,

18-21 October, 2001.


Title: National Kidney Foundation Of Egypt.

World Congress of Nephrology, Moscone Center, San Francisco, California, USA, 10-17 October 2001.

Title: End-Stage Renal Disease In Egypt.

Third International Congress Of The International Federation Of Kidney Foundations, Prague, Czech republic, 17-20

July, 2002.

Title: Implementation Of CAPD Program In Egypt.

Title: Renal Osteodystrophy and Cardiac Calcification in Hemodialysis Patients.

First International Congress of Nephrology, Baghdad, Iraq, May 2002.

Title: Pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.

Fourth biennial conference of nephrology, Pakistan, April 4-6 2003.

Title: End-stage renal disease around the world.

Title: Renal osteodystrophy in developing countries.

Fourth International Congress Of The International Federation Of Kidney Foundations, Amsterdam, Netherlands, 4-7

june, 2003.

Title: Activities of the national kidney foundation of Egypt.

World Congress of Nephrology, Berlin, Germany, COMGAN meeting, June 7, 2003.

Title: Hemodialysis issues in Egypt.


Meeting of the Libyan Society of Nephrology, Benighazi, October 2007.

Title: Management of anemia of CKD.

6 th FME MEA & Africa Nephrology Forum, Berlin, Germany 2009.

Title: Can we prevent type 2 Diabetes?.

Activities

Foundation of The Egyptian Renal Registry:

First Annual Report of End-Stage Renal Disease in Egypt (1997).

Second Annual Report of End-Stage Renal Disease in Egypt (1998).

Third Annual Report of End-Stage Renal Disease in Egypt (1999).

Fourth Annual Report of End-Stage Renal Disease in Egypt (2000).

Fifth Annual Report of End-Stage Renal Disease in Egypt (2001).

Sixth Annual Report of End-Stage Renal Disease in Egypt (2002).

Foundation of The Egyptian National kidney Foundation.

President of The Egyptian National kidney Foundation (1997 –2003) with the implementation of the following activities:

Sponsored a training course in nephrology at Sheffield kidney institute,

UK (February 1998).

Renal Osteodystrophy symposium (1998).


Travel grant for one scholar to EDTA congress, Madrid (1999).

Training coursed for dialysis nurses working at Al Sahel Hospital (1998).

Starting CAPD program at Al Sahel Hospital (1999).

Training Course for nurses on Peritoneal dialysis (1998).

Training Course for nurses on Peritoneal dialysis (1999).

Social workers workshop (1999).

Dieticians workshop (1999).

Publications: A guide to nutrition for ESRD patients (1999), in Arabic.

National Kidney Foundation week, May 2001: (Included)

•Doctors training course on diet in renal diseases.

•Doctors training course on PD.

•Nurses training course on PD.

•Dieticians training course.

•Social workers course.

Procedures in nephrology symposium.

•Nephrology quiz.

•Ask the professor.


President of the Egyptian Society of Nephrology Congress, 4-8 February 2002, Sharm El Sheikh, Egypt.

Organizer of Training workshop "Hemodialysis from A-Z, 2006)



Books:

1. Understanding kidney Diseases, 1st edition, 1996.

2. A manual of nutritional guidelines for renal disease patients “In Arabic”.

3. Understanding kidney Diseases, 2nd edition, 2002.

4. The kidney, caring, protecting and curing “In arabic”.

Publications

Study of Effects of Raised Serum Aluminium on Neurologic Functions in Dialysis Patients.


Mohamed MA., Mostafa M., El-Said W., Abdel Fattah M., Shawkt A., Afifiy A., Khedr E.

Menoufia Med.J. Vol. 1 No. 1, 3-12, July 1989

Beta 2 Microglobulin and alpha 2 Macroglobulin As Sensitive Indices For The development Of Diabetic Nephropathy; A Clinico-Pathologic

Study.

Afify A., Mady G., Mamoun M., Labib B., Fadila Sabry, Helil E., Abdelfattah MA., Shawkat A., Fadila Gadalla.

XI th. International Congress of nephrology, July 15-20, 1990, Tokyo, Japan.

Effect of Low Dose sodium Nitroprusside on Peritoneal Clearance In Man.

Afify A., El Said W., Shadia Barakat., Abdel Fattah M., Eman El Azab.


Complications of Therapeutic Aphresis.

Gohar S., Afify A., Abdel Fattah M., Mahdy M., Barakat S.

Third International Sorrento Meeting On Current Therapy In Nephrology, 1990, Napoli, Italy.

Acquired Immunodefficiency Syndrome among hemodialysis Patients In Egypt.

Abdelfattah M., El Said M., Rasha Khalil., Mohamed O., Afify A., Khedr E.



Etiology of Acute Renal Failure Among Egyptian Infants and Children.

El-Said W., Farid F., Abdel-Fatah M., Afify A., Abou-Seif KH., Moussa A.

Proceedings of the XII Annual Congress Of Egyptian Society of Nephrology, 90-94, February, 1992

Anthropometric Mesurements and its Value in Determination of Dry Body Weight in Dialysis Patients.

Mahmoud Abdel Fattah, Mohamed El-Tayeb, Gamal Mady, Adel Afifi, Ahmed Abdul Kader.

Proc. Of the 15th. Internatioal annual Ain Shams Medical Congress, 179-182, February, 1992

Ultrafiltration in The Treatment of Refractory Cardiac Edema.

Abdel-Fattah M., Taher M.A., Afify A., Abou-seif Kh., Khedr E., Zaki M.


Plasmapheresis in Systemic Lupus Erythematosus.

Ismail M.I., W. El Saied., F. Tamara., M.El Shafe., R. Khalil., M.Abd El Fattah., A.Afify., M.El Tayeb., Gamal Mady.


Prevalence of Hepatitis C Virus Antibodies Among Hemodialysis Patients.

Yehia A-R Awadallah, Adel Afifi, Jamil AR Parkar, Ryaz M. Makhdomi.

Az.J.Microbiol., Vol. 18, October 1992

Use of Non Steroidal Anti-Inflammatory Drugs in Treatment of Nephrotic Syndrome.


B.Labib., M.A. Al Fattah., M.A. Hamed., E. Khedr., G. Mady., M.El Tayeb., A. Afify.


Bacterial Urinary Tract Pathogens in the Nineties.

Afifi A., Bassima Al Essawi.

The New Egyptian Journal of Medicine, Vol.8, No.3, 896-898, 1993.

Effect of Blood Recirculation During Hemodialysis on Dialysis Efficiency.

El-Said W., Abdel Fattah M., Khedr E., Afifi A., Ahmed M.


Radiocontrast Media Nephrotoxicity in Patients undergoing Cardiac Angiography.

Afifi A., Wafa S.

Proceedings of the International Satellite Symposium on Acute Renal Failure ( Sponsored by ISN) , 20-23 June 1993, Hakidiki, Greece.

Predictors of The Development Of Acute Renal Failure In Open Heart Surgery Patients.

Bedair S., Sabri H., Khedr E., Afify A., Essawy G.


Etiology of Chronic Renal Failure Among A Sample Of The Egyptian Population.

Afifi A., Madi G., El Sawy M., Reda T. Ain Shams Medical Journal, Vol. 50 No. 7,8 & 9 , 711-718, 1999


Renal Replacement Therapy In Egypt: First Annual Report Of The Egyptian Society Of Nephrology, 1996.

A.Afifi , M.A. Karim.

WHO, Eastern Mediterranean Health Journal, Vol.5, No. 5, 1999

Pregnancy Related Acute Renal Failure in A Sample of The Egyptian Population And The Effect Of Different Treatment Modalities.

Afifi A., Sarhan I., Alyian A., Abed El-Qader A., Abed El-Rahman A., Eskander E.

Journal of the Egyptian Society of Nephrology, 2(1) Jan., 2000

Dobutamine Echocardiography For Evaluation of Coronary Artery Disease In Hemodialysis Patients.

Eman El-Azab, Adel Afifi, Hesham El-Saied, Gamal Made, Sahar Shawky, Samir Wafa.

African Journal of nephrology, 6:30-35, 2002

Management of Pre-endstage Renal Failure in Egypt

Rashad Barsoum., Adel Afifi., Ibrahim Bazzal., Enas El-Sayed.

Saudi Medical Journal, vol. 13 No. 3 September 2002.

Renal Osteodystrophy In Developing Countries. Afifi A.

Artificial Organs

2002 sep; 26(9): 767-9, Blackwell Publishing, Inc.


© 2002 International Society for Artificial Organs

Hemodialysis vascular access among chronic renal failure patients in Egypt”

Adel Afifi, Hani Refaat, Abdel monem Wahba, Maged Abdel Karim and Racha Fayez.

The Journal of vascular access 2002;3:120-6

Effects of smoking and Lead exposure on proximal tubular integrity among Egyptian industrial workers.

Ibrahim El-Safty, Adel Afifi, Ahmed Shouman, and Ahmed El-Sady.

Archives of medical research 35 (2004) 59-65

Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a

six-year study.

A. Afifi, M. El Setouhy, M. El Sharkawy, M. Ali, H. Ahmed, O. El-Menshawy and W. Masoud

Eastern Mediterranean Health Journal, Vol. 10, Nos 4/5, 2004

Pattern of renal disease among elderly egyptians with acute or chronic renal disease in Ain Shams University and Nasser institute hospitals, Cairo,

Egypt.

Afifi AM, Mady GE, et al. J Egypt Soc Parasitol. 2005 Dec;35(3):911-924

Hyperphosphatemia among end-stage renal diseas patients in developing countries; A forgotten issue?

Adel Afifi, Hesham El-Sayed, Maged El-Setouhi, Hayam Ahmed, Noha Khalifa.

Hemodialysis International 2005; 9: 409-415

Hepatitis C Virus Infection Among Hemodialysis Patients in Developing Countries; a Major Health Problem.

Adel Afifi, and Walid Abdel Mohsen.


5th congress of nephrology in internet - 5to congreso de nefrologia en internet, CIN 2009


Professor Abdel Meguid EL NAHAS

PROFESSIONAL QUALIFICATIONS and TRAINING

1974 Certificat de Fin d’ Etudes Medicales, Geneva, Switzerland

Trained in Geneva (74-76), Paris (78-79) and London (79-82)

Trained at Harvard Medical School (77-78) & Royal Postgraduate

Medical School, Hammersmith Hospital (London) (79-82)

1980 Member of the Royal College of Physicians (MRCP)

1984 PhD Degree Nephrology/Immunology, University of London

1990 Fellow of the Royal College of Physicians (FRCP)

CERTIFICATION AND LICENSURE

1976 ECFMG (USA)

1984 Full Registration, General Medical Council, UK

1986 Accreditation as specialist in General Internal Medicine

and Nephrology, Royal College of Physicians, UK


ACADEMIC POSITION

1996- Professor of Nephrology

University of Sheffield

1986 Consultant Renal Physician

Sheffield Teaching Hospitals Trust

Northern General Campus, Sheffield Kidney Institute

Sheffield, UK

2000-2002 Head of Department of Medicine

Division of Clinical Sciences (North)

Sheffield Teaching Hospitals

Northern General Hospital Campus, Sheffield

1993-1998 Director of Medical Education

Northern General Hospital

1995 Founder of Sheffield School of Nephrology (SSN)

and the Diploma/Masters courses in Nephrology

MEMBERSHIP OF PROFESSIONAL SOCIETIES

1984- The British Renal Association

1986- The European Dialysis and Transplantation Association

1987- The International Society of Nephrology

1989- The European Cell Biology Group

1991- The International Society of Nutrition and Metabolism

in Renal Disease


1991- The Association of Physicians of Great Britain

1993- The European Kidney Research Forum

1996- The American Society of Nephrology

1997- Association of Clinical Professors of Medicine

1997- Fellow of the Royal Society of Medicine

2000- The International Society of Nephrology

2009- ISN Council member

2009- EDTA/ERA Glomerulonephritis working group

2009- EDTA/ERA Education Committee member

MEMBERSHIP OF EDITORIAL BOARDS

1990-2000 International Yearbook of Nephrology

1991-1996 Kidney International

1991-2000 Journal of Experimental Nephrology (Associate Editor)

1993-2000 Nephrology Dialysis Transplantation (Subject Editor)

1996- Kidney Forum (Consulting Editor and Co-Founder)

2002-2004 Journal of the American Society of Nephrology

2002-2004 American Journal of Kidney Diseases (Associate Editor)

2005- Journal of the American Society of Nephrology-Clinical Nephrology

2008- Editor Nephron Clinical Practice

MEMBERSHIP OF COMMITTEES

The steering committee of the European Study on ACE inhibition

in Non-Diabetic Nephropathy (Benazepril Study) 1992-1995

The MRC steering committee of the United Kingdom Prospective


Diabetes Study (UKPDS) 1997-2001

The MRC Medical Advisory Board (MAB) 1999-2004

The RSM Nephrology Section committee 2000-2002

International Society of Nephrology (ISN) Committee for the

Global Advancement of Nephrology (COMGAN) 2000-

INSERM (French MRC) Scientific Advisory Board 2000-

ISN (COMGAN) Research advisory board 2002-

Chairman of the British Renal Association International Committee 2004-2007

Swiss Research Foundation EU Expert 2005-

Member ISN Renal Sister Center committee 2005-

ISN Middle East Research Coordinator 2005-

Chairman of KDIGO CKD classification committee 2006-2009

Expert advisor to Department of Health UK (MHRA)

Cardiology, Diabetes and Renal Medicines board 2006-2009

European Medicinal Agency (EMEA) Expert 2007-

Global Burden Disease WHO Expert Panel 2008-

EU COST UK Representative 2008-

KDIGO CKD Co-Chair 2009-

ISN Council member 2009-

EDTA/ERA Glomerulonephritis working group 2009-

EDTA/ERA Education committee member 2009-


AWARDS

1998 Arab Society of Nephrology Gold Medal

2003 International Society of Nephrology Education and Training Award

2004 Arab Society Nephrology & Renal Transplantation Career Achievement Award

2004 Tunisian Society of Nephrology Medal

2006 Egyptian Society of Nephrology : Career achievement award

2008- Turkish Society of Nephrology Life membership Award

RESEARCH INTEREST AND EXPERTISE

My main interest has been the study of the mechanisms underlying progressive chronic kidney disease (CKD) and the

factors influencing its progression. Over the last 30 years, the research undertaken at the Sheffield Kidney Institute, under

my direction, has been a leader in the UK and internationally in the field of the study of mechanisms of progressive CKD

and their prevention. This has led to major advances in the field. The evaluation of experimental and clinical interventions

aimed at slowing progressive kidney insufficiency.

PUBLICATIONS

In excess of 200 publications in peer-reviewed journals

Editor: 5 Handbooks of Nephrology

Email: [email protected]

mailto:[email protected]


ANTOINE BARBARI, M. D.

PERSONAL HISTORY:

Business Address: Rafik Hariri University Hospital

Bir Hassan, Beirut- Lebanon

Phone: +9611831554 -1566-2040


Fax: +9611832041

Mobile: +961332655

E-mail: [email protected]

Home Address: Batroun 4001 - Lebanon

Tel: 961-6-742624

Date of Birth: September 28, 1955

Place of Birth: Lebanon

Citizenship: Lebanese - American

Marital Status: Married, 3 Children

Languages: Arabic (Native)

English

French

Spanish

EDUCATION:

One year of Major in Physics 1973-1974

Faculty of Sciences, University of Lebanon

Medical School 1974-1981

Faculty of Medicine of Montpellier,

University of Montpellier, France

Internship Internal Medicine 1980-1981 University Medical Center, Saint Eloi

Montpellier, France

One year of Residency in Nephrology 1982-1983

University Medical Center, Saint Charles

Montpellier, FrancePage 2 of 24

Post-graduate Researcher 1983-1984

Clinical Department of Inernal Medicine

Nephrology Division, UCI Medical Center

(N.D. Vaziri, M.D.)


Research Fellow, Nephrology Division 1984-1985

UCI College of Medicine, Ivrine, CA

(N.D. Vaziri)

Research Fellow, Nephrology Division 1985-1986

UCI College of Medicine, Ivrine, CA

(N.D. Vaziri)

Internal Medicine Residency Training 1987-1990

St. Francis Hospital, Evanston, IL

Nephrology Clinical Fellowship 1990-1991

University of California Los Angeles

LICENCE:

Lebanon Licence : 4773 1993

Illionis Licence : 036-077636 1988

California Licence : A46395 1989

CERTIFICATION:

E.C.F.M.G. 1981

V.Q.E. 1983

Flex 1983

Nephrology Research Fellowship 1986

American Board of Internal Medicine 1990

American Board of Nephrology (Eligible) 1992

PERSONAL EXPERIENCE:

Lebanese American University 2008

Founding Medical Faculty

Director, Renal Transplant Unit 2006-present

Rafik Hariri University HospitalPage 3 of 24


Program Director of Medical Education 1998-2006

Rizk Hospital,

Department Head, Internal Medicine 1998-2000

Rizk Hospital

Program Director, Peritoneal Dialysis 1994-2005

Rizk Hospital

Program Director of Medical Education 1993-1994

Rizk Hospital

Assistant Professor of Medicine, UCLA 1991-1992

Medical Director, Inpatient Dialysis

and Outpatient Peritoneal Dialysis,

Harbor-UCLA Medical Center

Nephrology Clinical Fellow 1990-1991

UCLA Medical Center

Clinical Instructor – UC Irvine 1986-1987

College of Medicine, CA

Nephrology Research Fellow – Teaching 1984-1986

and Supervising Premed and Medical

Students, UC Irvine College of Medicine, CA

PROFESSIONAL ACTIVITIES:

Association of Clinical Faculty

UC Irvine College of Medicine

Arab Society of Nephrology and Transplantation, Member

Lebanese Society of Nephrology, Member

Middle East Society for Organ Transplantation

(MESOT), Member

Asian Society of Transplantation, Member

International Society of Nephrology Member

American Society of Nephrology, Member


American College of Physicians, Member

The Transplantation Society, MemberPage 4 of 24


American Medical Association Ex, Member

Vice-Chairman and Founder Member of the 1985-1987

Kidney Patients Support Group of Orange

County, CA

Vice-President and Founder Member of the 1994-2002

Association “Bayader El Mahaba”

Vice-President of “ADHD” Parents 1999-Present

Association and Founder Member

Batroun’s Youth Encounter” – Founder 1998-Present

Chairman of the Scientific Committee of 2000

7th Congress of Middle East Society of

Organ Transplantation (MESOT)

Middle East Society of Organ Transplantation 2004-2008

Council Member, Lebanon Representative

Asian Society of Transplantation 2004-present

Council Member, Lebanon Representative

Arab society of Nephrology and Renal 2008

Transplanation, Lebanon Representative

Experimental and Clinical transplantation 2008

Journal, Editorial Board Member

Istanbul Declaration Steering Committee 2008

Member

Middle East Society of Organ Transplantation 2008

Vice-President

The Transplantation Society, 2008

Lebanon’s country liaison officer

11th Congress of the Asian Societyof 2008-2009 Transplantation 2009, President

HONORS AND SPECIAL AWARDS:

Annual Fellowship Research Competition Award 1985


University of California, Ivrine

Annual Meeting of the American College of 1986

Physicians AwardPage 5 of 24

Syrian Society of Nephrology special award 2007

for academic achievement

LECTURES AND PRESENTATIONS:

1. Annual Fellowship Research Competition, 1985

UC Irvine College of Medicine, CA

Pahl MV; Intestinal absorption of

arachidonic acid in experimental azotemia.

Barbari A; Vaziri ND; Hollander D; Sanchez M;

Oveisi F; Patel N. Life Sci 1990 46(23):1649-56

2. Annual Symposium of Nephrology, 1985 Faculty of Medicine of Buenos Aires,

Argentina.

Effect of experimental azotemia on intestinal

transport of butyric acid. Vaziri ND; Barbari A;

Hollander D; Vincent T; Tran L ; Oveisi F ;

Pahl MV ; Bissar L. Proc Soc Exp Biol Med 1989

Feb; 190 (2): 150-4

3. Annual Fellowship Research Competition, 1986

UC Irvine College of Medicine, CA

Intestinal absorption of linoleic acid in

experimental azotemia. Barbari A; Pahl MV;

Vaziri ND; Hollander D; Mazdani M; Tran J;

Sanchez M. British J Nutr. 1991; 66 (3):467-77

4. Annual Regional Meeting of the American 1986

College of Physicians of Southern

California and Hawai, Los Angeles, CA.


Intestinal absorption of linoleic acid in

experimental azotemia. Barbari A; Pahl MV;

Vaziri ND; Hollander D; Mazdani M; Tran J;

Sanchez M. British J Nutr. 1991; 66(3):467-77

5. Morbidity and Mortality Grand Rounds 1988

Saint Francis Hospital, ILL

The pulmonary – Renal syndromes

Antoine Barbari, MD.

6. Geriatrics Medicine Grand Rounds 1989


The aging kidney.


7. Medical Grand Rounds 1989


Approach to complex acid-base disturbances.Page 6 of 24


8. Nephrology Grand Rounds 1991

UC Los Angeles School of Medicine

Post-Partum Acute renal failure.


9. Nephrology Grand Rounds 1992

Harbor-UCLA Medical Center

Pregnancy – related Thrombotic

Microangiopathies.


10.Lebanese Society of Nephrology Meeting 1993

Peritoneal Dialysis update.


11.Lebanese Faculty of Medicine Grand Rounds 1995

Diabetic Nephropathy.



12.Fourth African and Pan Arab Society of 1995

Nephrology and Transplantation meeting

Consanguinity related kidney diseases

in Lebanon: An Epidemiology study.

Barbari A; Stephan A; Masri M; Aoun S;

Nahas J; Abou Khalil J.

13. Fourth African and Pan Arab Society 1995

of Nephrology and Transplantation

Session chairman

14. Second Pan Arab Hypertension Congress 1995

Session Chairman

15. Rizk Hospital Grand Round 1996

Consanguinity – related kidney diseases

in Lebanon.

Antoine Barbari, M.D.

16. Fifth Middle East Society for Organ 1996

Transplantation Congress (MESOT). Limassol,

Cyprus. Consupren and Neoral in renal Transplant

patients. Barbari A; Stephan A; Masri M; Kamel G;

Kilany H. Transplant Proc. 1997 Nov; 29 (7): 2941-44



Cyprus. A two year study of the new cyclosporine

(CyA) Formulation Consupren in denovo renal

Transplant patients. Stephan A; Barbari A; Page 7 of 24

Masri MA; Kamel G; Karam A; Kilany H and al.

Transplant Proc. 1998 Nov; 30(7): 3563-4.



Cyprus. Correlation between cyclosporine

pharmacokinetics and immunological parameters in

dialyzed patients awaiting transplantation.


Masri MA; Barbari A; Kamel G; Karam A and Stephan A.

Transplant Proc. 1997 Nov; 29(7):2953-4.



Cyprus. Cyclosporine pharmacokinetics in stable

renal transplant patient: Effect of formulation,

Sandimmun Vs Consupren Vs Neoral. Masri MA;

Stephan A; Barbari A; Kamel G; Frem G; Younan F;

Rizk S; Moubarak R and Karam A. Transplant Proc.

1996 June; 28(3) : 1318-1320.



Cyprus. Donor specific transfusion under the new

cyclosporine formulation vs Azathioprine. Kamel G;

Stephan A; Barbari A; Masri M and Younan F.




Cyprus. Comparative study of HLA alleles frequency

in Lebanese, Arabs, United Arab Emirates and East

Indian populations. Masri MA; Stephan A; Barbari A;

Rizk S and Kamel G. Transplant Proc. 1997 Nov; 29(7):

2922-23.


Transplantation Congress (mesot). Limassol,

Cyprus. Immunosuppressive Therapy in renal

Transplant patients according to immunological

status. Masri MA; Stephan A; Kamel G; Barbari A;

Kilany H and Rizk S. Transplant Proc. 1997 Nov;

29(7): 2951-2952.

23. Fifth Congress of the Arab Nephrology and Renal 1997

Transplantation Society . Lebanon.

One year comparative Study of Sandimmun Neoral


vs Consupren in Denovo transplant patients.

Stephan A; Barbari A; Kamel G; Aoun S; Masri M;

Rizk S. Transplant Proc. 1998 Nov; 30(7): 3533-4.

24. Fifth Pan Arab Society of Nephrology and 1997Page 8 of 24

Transplantation Congress. Session chairman

25. Fifth Asian Society for Organ Transplantation. 1997

Measurment of Cyclosporine lymphocyte levels in

transplant patients. Masri MA; Stephan A; Barbari

A; Rizk S; Kilany H and Kamel G. Transplant Proc.

1998 Nov; 30(7): 3561-2.

26. Fifth Asian Society for Organ Transplantation. 1997

Transplantation at Rizk Hospital: 10 years

experience. Kamel G; Stephan A; Barbari A;

Karam A and Masri MA. Transplant Proc. 1998 Nov;

30(7): 3114-5.

27. Abu Dhabi Post-Graduate Course. Angiotensin II 1998

Receptor Antagonist Workshop.

28. Sixth Middle East Society for Organ 1998

Transplantation Congress (MESOT), and the 3rd SIUT.

Karachi, Pakistan. ACE Inhibitors and Acute Ischemic

Renal Failure. Stephan A; Barbari A; Karam A.


Transplantation Congress (MESOT),

and the 3rd SIUT. Karachi, Pakistan. A one center

experience with a short course of Mycophenolic Acid.

Stephan A; Barbari A; Karam A; Masri MA; Aoun S

and KamelG. Transplant Proc. 1999 Dec; 31(8): 3289-90.


Transplantation Congress (MESOT) and the 3rd SIUT.

Karachi, Pakistan. Safe and cost effective Conversion

for Neoral to Consupren soft capsules in stable renal

transplant patients, a one year study. Masri MA;


Stephan A; Barbari A; Rizk S and Kamel G. Transplant

Proc. 1999 Dec; 31(8): 3302-3.


Transplantation (MESOT) and the 3rd SIUT.

Masri MA; Stephan A; Barbari A; Rizk S and Kamel G.

Logical approach to transplant patient monitoring.

Transplant Proc. 1999 Dec; 31(8): 3353-5.

32. AAMA congress. 1999

Transplantation in Lebanon: past, present and

future.

33. Annual Research Competition, Lebanese 1999

University, Medical School.

Donor Specific Transfusion: long term results

under different immunosuppression protocols.Page 9 of 24

Barbari A; Stephan A; Gebran N; Masri M; Kamel G;

Kilani H and Karam A.

34. Recent Advances in Tissue and Organ 1999

Transplantation - Turkey

Cyclosporine formulations is there a difference?

Masri MA; Stephan A; Barbari A; Rizk S and

Kamel G. Transplant Proc. 2000 Nov; 32(7): 1468-9.

35. 7th Congress of Middle East Society of 2000

Organ Transplantation (MESOT). Lebanon.

Cyclosporine Lymphocyte vs whole blood pharmaco-

kinetic Monitoring: Correlation with Histological

Findings. Barbari A; Masri M A; Stephan A; Mokhbat J;

Kilani H; Rizk S; Kamel G and Joubran N. Transplant

Proc. 2001 Aug; 33(5): 2782-5.

36. 7th Congress of Middle East Society of Organ 2000

Transplantation (MESOT). Lebanon.

Chronic Graft Dysfunction: Donor Factors.

Barbari A; Stephan A; Masri M A; Kamel G; Kilani H


and Barakeh A. Transplant Proc. 2001 Aug; 33(5):

2695-8.


Transplantation (MESOT). Lebanon. Donor Specific

Transfusion (DST) in Kidney Transplantation:

Effect of different immunosuppressive protocols

on graft outcome. Barbari A; Stephan A; Masri MA;

Joubran N; Dagher O and Kamel G. Transplant Proc.

2001 Aug; 33(5): 2787-8.


Transplantation (MESOT). Lebanon. Surgical

Complications in 272 consecutive renal

transplantation: A one center experience.

Kamel G; Stephan A; Barbari A; Zeineh S; Salmé P;

Masri MA; Kilani H and Karam A.

39. Seventh Congress of the Middle East Society of 2000

Organ Transplantation (MESOT). Lebanon

Therapeutic Drug Level Monitoring for Mycophenolate Mofetil (MMF): is it justified?

Stephan A; Masri MA; Barbari A; Kamel G; Karam A

and Kilani H. Transplant Proc. 2001 Aug; 33(5):2778-9.

40. The 4th Congress of Nephrology, Urology, 2001

Transplantation Society of SAARC Countries.

Karachi, Pakistan. Hyperlipidemia and graft loss.

Stephan A; Barbari A. Transplant Proc. 2002 Sep;

34(6): 2423-5.Page 10 of 24

41. The 4th International Symposium on Urology, 2001

Nephrology and Transplantation of SIUT.

Karachi, Pakistan. Updating Transplantation

Therapies in developing countries. Stephan A;

Barbari A. Transplant Proc. 2002 Sep; 34(6):


2475-7.

42. The 4th Congress of Nephrology, Urology, 2001

Transplantation Society of SAARC Countries.

Karachi, Pakistan. Nephron mass in kidney

transplantation. Barbari A; Stephan A. Transplant

Proc. 2002 Sep; 34(6): 2401-2.

43. 2nd Introductory course on Transplant Procurement 2001

Management, Zahleh – Lebanon. Organ viability

in kidney transplantation.


44. MSD Symposium. Angiotensin Blockade in reno- 2001

cardiovascular pathology.


45. Rizk Hospital Grand Round: Peritoneal 2002

Dialysis at Rizk Hospital.


46. Peritoneal Dialysis congress of the Lebanese 2002

Society of Nephrology Symposium. Peritoneal

Dialysis problems and outcome in Lebanon.

Antoine Barbari, MD

46. 3rd Introductory course on Transplant Procurement 2002

Management, Tripoli – Lebanon.

Organ viability in kidney transplantation.


47. Eighth International Congress of the Middle 2002

Society for Organ Transplantation (MESOT). Muscat,

Oman. ACE Inhibitors and the hypoperfused graft.

Stephan A; Barbari A; Kamel G; A Jaoude F; Kilani H;

Ghanem G and A Karam.




Oman. Cyclosporine A Lymphocyte level and

Lymphocyte count: New guidelines for Tailoring

Immunosuppressive Therapy. Barbari A; Stephan A;

Masri MA; Mourad N; Kamel G; Karam A; Kilani H

and Daya IA. Transplant Proc. 2003 Nov; 35(7): 2742-4.


Society for Organ Transplantation (MESOT). Muscat,Page 11 of 24

Oman. Textiloma in a kidney recipient: A rare

complication. Kamel G; Stephan A; Salmeh P;

Zeineh S; Barbari A; Kilani H; Karam A.



Oman. Obstructive anuria due to fungal Bezoar in

a renal graft recipient. Kamel G; Stephan A;

Salmeh P; Zeineh S; Barbari A; Kilani H; Karam A;

Khoury W, Mokhbat J and Husni R. Transplant Proc.

2003 Nov; 35(7): 2692-3.



Oman. Masri MA, Barbari A, Stephan A, Rizk S

and Kamel G. Technical limitation in therapeutic

drug monitoring: Transplant Proc. 2003 Nov;

35(7): 2755-6.

52. Koweit Society of Nephrology symposium. Koweit 2002

city. DARBEPOETIN alpha (ARANESP)from Bench to

Clinical application.



53. Symposium of the Marocan Society of Nephrology, 2003

Tanger. Relationship between hemoglobin and

survival.

Antoine Barbari , MD.

54. Symposium of the Marocan Society of Nephrology, 2003

Tanger. ARANESP: Clinical data. Antoine Barbari ,MD.

55. 4th Introductory course on Transplant Procurement 2003

Management. Organ viability in kidney

transplantation.


56. VIIIth Congress of Arab Society of Nephrology 2004

And Renal Transplantation and XXIII Annual

Congress of Egyptian Society of Nephrology:

Anemia and patient survival in patients with

ESRD, Antoine Babrbari, MD.

57. VIIIth Congress of Arab Society of Nephrology 2004

And Renal Transplantation and XXIII Annual

Congress of Egyptian Society of Nephrology:

Immunosuppression minimization,


58. First Nephrology Update meeting for the 2004

Lebanese Society of Nephrology. Tailoring Page 12 of 24

immunosuppression. Is it needed?


59. XXth International Congress of the 2004


Transplantation Society (Vienna). A

new alternative for Cyclosporine A monitoring

in kidney transplantation: Cyclosporine A

lymphocyte maximum level. Barbari A, Stephan A,

Mourad N, Kamel G, Karam A and Kilani H.

60. VIIIth African Congress of Nephrology and 2004

IVth Moroccan Congress of Nephrology. Anemia the

villain mediator in the cardio-renal syndrome,


61. Lebanese Society of Nephrology Symposium. 2004

Acute Humoral rejection,


62. IInd Kidney Hospital Congress. Syrian Society 2004

of Nephrology. Kidney transplantation and

immusosuppression tailoring,


63. IXth Congress of the Middle East Society for 2004

Organ Transplantation (MESOT). Ankara, Turkey.

Parameters affecting temporal variations of

CsA Lymphocyte maximum levels in stable de novo

kidney Transplant patients. Barbari A, Stephan A,

Masri M, Kamel G, El Ghoul B, Karam A, Kilani H.

Experimental and Clinical Transplantation Dec 2004;

vol 2(2): 12.



MPA plasma levels: Correlation with clinical

Outcome. Barbari A, Stephan A, Masri MA, Kamel G,


Karam A, Mourad N, Kilani H, El-Ghoul B.


vol 2(2): 44.



CsA lymphocyte maximum binding monitoring in de

novo kidney transplant patients. Barbari A,

Stephan A, Masri M, El Ghoul B, Kamel G, Karam A,

Kilani H. Experimental and Clinical Transplantation

Dec 2004; vol 2(2): 11.


Organ Transplantation (MESOT). Ankara, Turkey. Page 13 of 24

Sirolimus side effects. The different experience

of a single center. Stephan A, Barbari A, Kamel G,

Masri AM, Kilani H, Karam A. Experimental and

Clinical Transplantation Dec 2004; vol 2(2): 38.



Sirolimus, can we rely on the presently available

pharmacokinetics? Stephan A, Kamel G, Barbari A,





Living donor nephrectomy. A safe procedure in

our center. Stephan A, Barbari A, Kamel G,






Switchability of Neoral with Equoral according

to FDA rules and regulations. Masri MA, Haberal M,

Rizvi A, Stephan A, Bilgin N, Naqvi A, Barbari A,

Kamel G, Zafar N, Emiroglu R, Colak T, Manzoor K,

Matha V, Kamarad V, Andrysek T, Rizk S, Hazime A.


vol 2(2): 12.



A novel assay for the determination of the in vivo

bioactivity of Tacrolimus and Mycophenolate acid.

Masri MA, Rizk S, Barbari A, Stephan A, Kamel G.


vol 2(2): 44.


Organ Transplantation (MESOT) – Ankara, Turkey.

Mycophenolic Mofetil plasma level: Correlation

with Clinical Outcome. Barbari A, Stephan A,

Masri MA, Kamel G, Karam A, Mourad N, Kilani H,

El-Ghoul B. Experimental and Clinical Transplantation

Dec 2004; vol 2(2): 44.

72. IVth Think Kidney Symposium. Oman Society of 2005

Nephrology. Muscat, Oman. Calcineurin Inhibitors

minimization: Risk and benefits.


73. IVth Think Kidney Symposium. Oman Society of 2005


Nephrology. Muscat, Oman. Role of anemia in Page 14 of 24

the cardio-renal syndrome.


74. Rizk Hospital Grand Round. Drugs bioavailability 2005

and bioactivity.


75. Lebanese University Internal Medicine Department 2005

Grand Round: Thrombotic Microangiopathies.


76. Lebanese Society of Nephrology Symposium 2005

Corticotherapy minimization in renal

Transplantation.


77. IX Congress of the Asian Society of 2005

Transplantation. Humoral rejection.


78. IX Congress of the Asian Society of 2005

Transplantation. Immunosuppression monitoring:

Clinical relevance.


79. IX Congress of the Arab Society of Nephrology 2006 and Transplantation.

CalcineurinInhibitors Free Protocols.


80. Xth Congress of the Middle East Society for Organ 2006 Transplantation (MESOT).

Bioavailability vs bioactivity in clinical immunosuppression: Are they bioequivalent.



81. Xth Congress of the Middle East Society for Organ 2006 Transplantation (MESOT).Cyclosporine

A Whole

Blood Vs Lymphocyte Maximum Concentration:

Correlation with the Immune Response. Barbari A,

Masri M,Stephan A, Rizk S, Bou Khalil L, Kamel G,

Mourad N. Experimental and Clinical Transplantation

Dec 2006; vol 4(2): 58.

82. Xth Congress of the Middle East Society for Organ 2006 Transplantation (MESOT). Tacrolimus

Whole blood Vs

Lymphocyte Trough Level: Correlation with the

Immune Response. Barbari A, Masri M, Stephan A,

Rizk S, Bou Khalil L, Kamel G. Experimental and

Clinical Transplantation Dec 2006; vol 4(2): 58.Page 15 of 24

83. Xth Congress of the Middle East Society for Organ 2006 Transplantation (MESOT). Tacrolimus

Whole blood Vs

Lymphocyte Trough Level in De novo kidney

transplant patients: Clinical relevance .

Barbari A, Masri M, Stephan A, Rizk S,Bou Khalil L,

Kamel G. Experimental and Clinical Transplantation

Dec 2006; vol 4(2): 36.

84. Xth Congress of the Middle East Society for Organ 2006

Transplantation (MESOT). Factors influencing

the bioavailability and dosages of immunosuppressive

drugs. Masri M, Barbari A, Rizk S. Experimental and


85. Xth Congress of the Middle East Society for Organ 2006


Transplantation (MESOT). An assay for the

determination of Sirolimus levels in the lymphocyte of

transplant patients. Masri M, Rizk S and Barbari A.


vol 4(2): 59.

86. Stand alone Cilag-Jhonson Symposium (Jordan) 2007

Anemia the villain mediator in the cardio-renal

Syndrome.


87. Key Opinion Leader IST meeting (Ankara, Turkey) 2007 Novel approach in clinical

immunosuppression monitoring

Antoine Barbari, MD

88. Arab Society of Nephrology and Renal 2007

Transplantation Meeting (Egypt).Drug lymphocyte Level


89. Syrian Society of Nephrology 9th meeting. 2007

Renal Anemia in the context of the cardio-

Renal syndrome.

Antoine Barbari, MD


mTOR inhibitors in renal transplantation. Where

do we stand today?

Antoine Barbari, MD


Workshop on the new methodology in clinical

immunosuppression monitoring.

Antoine Barbari, MD


92. Xth Congress of the Arab Society of Nephrology 2008

and Renal transplantation. Future perspectives

in clinical immunosuppression monitoring. Page 16 of 24


93. Xth Congress of the Arab Society of Nephrology 2008

and Renal transplantation. CNI minimization

strategies: Current and future trends.


94. The International Association for Therapeutic 2008

Drug Monitoring and Clinical Toxicology Annual

Meeting. Drug lymphocyte level: New perspective

in clinical immunosuppression monitoring.

Antoine Barbari, MD

95. XIth Congress of the Middle Society of Organ 2008

Transplantation. Current and future strategies in

CNI minimization.


96. Annual Lebanese Society of Nephrology Meeting. 2009

Anemia and chronic kidney disease.

Antoine Barbari, MD

97. XIth Congress of the Asian Society of Organ 2009

Transplantation. Pharmacokinetics: what have

we learned?

Antoine Barbari, MD



Transplantation. Drug lymphocyte levels in clinical practice.

Antoine Barbari, MD


Transplantation. Whole blood Vs intra-cellular drug level monitoring: Which way to go?



Transplantation. Time average cyclosporine maximum intra-cellular level: simplified approach for

cyclosporine-a therapy monitoring. Barbari A, Masri MA, Stephan A, Rizk S, Younan F,

Bassil N,

ACTIVITIES AND PUBLICATIONS:

A. RESEARCH PAPERS – PEER REVIEWED

1. Vaziri ND; Barbari A; Licorish K; Cesario T; Gupta S;

Page 17 of 24

Spectrum of renal abnormalities in acquired immune-

deficiency syndrome. J Natl Med Assoc 1985 May;

77(5): 369-75.

2. Vaziri ND; Said HM; Hollander D; Barbari A; Patel N;

Dang D; Kariger R. Impaired intestinal absorption of

Riboflavin in experimental uremia. Nephron 1985;

41(1): 26-9.

3. Vaziri ND ; Toohey J ; Powers D ; Keegan K ; Gupta ;

Alikhani S; Mashood M; Barbari A. Activation

of intrinsic coagulation pathway in pre-eclampsia.

Am J Med 1986 Jan; 80(1): 103-7.

4. Vaziri ND ; Barbari A ; Hollander D ; Vincent T ;

Tran L; Oveisi F ; Pahl MV ; Bissar L. Effect

of experimental azotemia on intestinal transport

of butyric acid. Proc Soc Exp Biol Med 1989 Feb;


190(2): 150-4.

5. Barbari A; Vaziri ND; Benavides I; Chen YT; Said H;

Pahl MV. Intestinal transport of pyridoxine in

Experimental renal failure. Life Sci 1989; 45(7):

663-9.

6. Pahl MV; Vaziri ND; Barbari A; Saadai B; Oveisi F;

Seo M. Intestinal absorption of L-ascorbic acid

in rats with renal failure. Proc Soc Exp Biol

Med 1989 Sept; 191(4): 332-6.

7. Pahl MV; Barbari A; Vaziri ND; Hollander D;

Sanchez M; Oveisi F; Patel N. Intestinal absorption

of arachidonic acid in experimental azotemia.

Life Sci 1990; 46(23): 1649-56.

8. Barbari A; Pahl MV; Vaziri ND; Hollander D; Mazdani M;

Tran J; Sanchez M. Intestinal absorption of

Linoleic acid in experimental azotemia. British

J Nutr 1991; 66(3): 467-77.

9. Ansari A; Barbari A; Vaziri ND; Pahl MV. Cardiac

pathology in patients with end stage renal

disease maintained on hemodialysis. Int J Artif

Organs 1993; 16(1): 31-36.

10. Stephan A; Barbari A; Masri MA; Frem G; Kamel G;

Rizk S; Moubarak R; Khoury W and Karam A. Evaluation

of new cyclosporine formulation Consupren in renal

transplant patients. Transplant Proc. 1996 June;

28(3): 1348-49.

11. Masri MA; Stephan A; Barbari A; Kamel G; Frem G;


Younan F; Rizk S; Moubarak R and Karam A. Cyclosporine Page 18 of 24

pharmacokinetics in stable renal transplant patient:

Effect of formulation, Sandimmun v/s Consupren v/s

Neoral. Transplant Proc. 1996 June; 28(3): 1318-1320.

12. Masri MA; Barbari A; Kamel G; Karam A and Stephan A.

Correlation between cyclosporine pharmacokinetics and

immunological parameters in dialyzed patients awaiting

transplantation. Transplant Proc. 1997 Nov; 29(7):

2953-2954.

13. Kamel G; Stephan A; Barbari A; Younan F and Masri MA.

Donor specific transfusion (DST) under the new

cyclosporine formulation (Consupren, CON) v/s

Azathioprine (Imuran, IM). Transplant Proc. 1997 Nov;

29(7): 2960-2961.

14. Barbari A; Stephan A; Kamel G; Kilany H and Masri MA.

Experience with new cyclosporine formulations Consupren and Neoral in renal transplant patients.


15. Masri MA; Stephan A; Barbari A; Rizk S and Kamel G. A

Comparative study of HLA alleles frequency in Lebanese, Arabs, United Arab Emirates and East

Indian

populations. Transplant Proc. 1997 Nov; 29(7):2922-2923.

16. Masri MA; Stephan A; Kamel G; Kilany H; Barbari A and

Rizk S. Immunosuppressive therapy in renal transplant

patients according to immunological status. Transplant

Proc. 1997 Nov; 29(7): 2951-2952.

17. Stephan A; Barbari A; Masri MA and Kamel G. A two year

study of the new cyclosporine (CyA) formulation

Consupren in denovo renal transplant patients.


18. Stephan A; Masri MA; Barbari A; Aoun S; Rizk S and

Kamel G. A one year comparative study of Sandimmun


Neoral v/s Consupren in denovo transplant patients.


19. Masri MA; Stephan A; Barbari A; Rizk S; Kilany H and

Kamel G. Measurment of lymphocyte cyclosporine levels

in transplant patients. Transplant Proc. 1998 Nov;

30(7): 3561-2.

20. Kamel G; Stephan A; Barbari A; Karam A and Masri MA, P

Salme, S. Zeineh, J. Mokhbat, R. Ghobril and W. Khoury-Barakat. Transplantation at Rizk

Hospital: 10 years experience. Transplant Proc. 1998 Nov; 30(7): 3114-5.

21. Masri MA; Stephan A; Barbari A; Rizk S and Kamel G. Page 19 of 24

Future trends in transplant therapy monitoring.


22. Stephan A; Barbari A; Karam A; Masri MA; Aoun S and

Kamel G. A one center experience with a short course of Mycophenolic Acid. Transplant Proc. 1999

Dec; 31(8): 3289-90.

23. Masri MA; Stephan A; Barbari A; Rizk S and Kamel G.

Safe and cost effective conversion for Neoral to

Consupren soft capsules in stable renal transplant

patients, a one year study. Transplant Proc.

1999 Dec; 31(8): 3302-3.

24. Masri MA; Stephan A; Barbari A; Rizk S and Kamel G.

Logical approach to transplant patient monitoring.

Transplant Proc. 1999 Dec; 31(8): 3353-5.

25. Masri M A; Stephan A; Barbari A; Kilani H; Kamel G and

al. Cyclosporine Formulations: Is there really a

difference? Transplant Proc. 2000 Nov; 32(7): 1468-9.

26. Stephan A; Masri M A; Barbari A; Kamel G; Karam A and

Kilani H. Therapeutic Drug Level Monitoring for

Mycophenolate Mofetil (MMF): is it justified?

Transpl Proc. 2001 Aug; 33(5): 2778-9.

27. Barbari A; Masri M A; Stephan A; Mokhbat J; Kilani H;

Rizk S; Kamel G and Joubran N. Cyclosporine Lymphocyte


vs whole blood pharmacokinetic monitoring: Correlation

with histological findings. Transpl Proc. 2001 Aug;

33(5): 2782-5.

28. Barbari A; Stephan A; Masri M A; Kamel G; Kilani H and

Barakeh A. Chronic Graft Dysfunction: Donor Factors.

Transpl Proc. 2001 Aug; 33(5): 2695-8.

29. Barbari A; Stephan A; Masri M A; Joubran N; Dagher O

and Kamel G. Donor Specific Transfusion (DST) in Kidney Transplantation: Effect of different

immunosuppressive protocols on graft outcome. Transpl Proc. 2001 Aug; 33(5): 2787-8.

30. Chammas E, El-Khoury J, Barbari A, Kamel G, Karam A,

Tarcha W, Ghanem G, Stephan A.

Early and late effects of renal transplantation on

cardiac functions. Transplant Proc. 2001 Aug; 33(5):

2680-2.

31. Stephan A; Barbari A; Karam A; Kilani H; Kamel G and

Masri M. Hyperlipidemia and graft loss.

Transplant Proc. 2002 Sep; 34(6): 2423-5.Page 20 of 24

32. Stephan A; Barbari A; Karam A; Kamel G; Kilani H and

Masri M. Updating Renal Transplantation Therapies in

Developing Countries. Transplant Proc. 2002 Sep;

34(6)2475-7.

33. Barbari A; Stephan A; Kilani H; Karam A; Kamel G and

Masri M. Nephron Mass in Kidney Transplantation.

Transplant Proc. 2002 Sep; 34(6): 2401-2.

34. Masri MA, Barbari A, Stephan A, Rizk S, Kamel G. Pre-

and posttransplant immunologic monitoring: Why, when,

and how? Transplant Proc. 2002 sep; 34(6): 2482-4.

35. Masri MA, Barbari A, Stephan A, Rizk S, Kamel G.


Cytokine gene polymorphism in a Lebanese transplant

population and its impact on graft acceptance: a

single–center pilot study. Transplant Proc. 2003 Feb;

35(1): 251-2.

36. Yammine JN, Yatim A, Barbari A. Radionuclide imaging

in thoracic splenosis and a review of the literature.

Clin Nucl Med. 2003 Feb; 28(2): 121-3.

37. Barbari A; Stephan A; Masri MA; Aoun S; Nahas J and

Abou Khalil J. Consanguinity-associated kidney

diseases in Lebanon: An epidemiology study. Mol

Immunol. 2003 Jul; 39(17-18): 1109-14.

38. Barbari, A. Stephan, M. Masri, N. Mourad, G. Kamel, A.

Karam, H. Kilani and I. A Daya. Cyclosporine A

Lymphocyte level and Lymphocyte count: New guidelines

for Tailoring Immunosuppressive Therapy. Transplant

Proc. 2003 Nov; 35(7): 2742-4.

39. Kamel G; Stephan A; Salmeh P; Zeineh S; Barbari A;

Kilani H; Karam A; Khoury J; J Mokhbat and R

Husni.Obstructive anuria due to fungal Bezoars in a

renal graft recipient. Transplant Proc. 2003 Nov;

35(7): 2692-3.

40. Masri MA, Barbari A, Stephan A, Rizk S and Kamel G.

Technical limitations of immunosuppressive drug

therapy blood level monitoring. Transplant Proc. 2003

Nov; 35(7): 2755-6.

41. Masri MA, Haberal M, Rizvi A, Stephan A, Bilgin N,


Naqvi A, Barbari A, Kamel G, Zafar N, Emiroglu R,

Colak T, Manzoor K, Matha V, Kamarad V, Rizk S, Itany

AR, Shehedeh I. The pharmacokinetics of equoral versus

neoral in stable renal transplant patients:

Multinational multicenter study. Transpl Proc. 2004 Page 21 of 24

Jan-Feb; 36(1): 80-3.

42. Barbari A, Masri M, Stephan A, Mourad N, Kamel G,

Karam A and Kilani H. A new alternative for CsA

monitoring in kidney transplantation: Cyclosporine A

lymphocyte maximum level. Transplantation 2004; vol

28(2): 257, A183.

43. Barbari A, Stephan A, Masri M, Kamel G, El Ghoul B,

Karam A, Kilani H. Parameters affecting temporal

variations of CsA Lymphocyte maximum levels in stable

de novo kidney Transplant patients. Experimental

and Clinical Transplantation Dec 2004; vol 2(2): 12.

44. Barbari A, Stephan A, Masri MA, Kamel G, Karam

A, Mourad N, Kilani H, El-Ghoul B.MPA plasma levels:

Correlation with clinical Outcome. Experimental and


45. Stephan A, Barbari A, Kamel G, Masri AM, Kilani H,

Karam A. Sirolimus side effects. The different

experience of a single center. Experimental and


46. Stephan A, Kamel G, Barbari A, Masri AM, Kilani H,

Karam A. Sirolimus, can we rely on the presently

available pharmacokinetics? Experimental and Clinical


Transplantation Dec 2004; vol 2(2): 39.

47. Stephan A, Barbari A, Kamel G, Masri AM, Kilani

H, Karam A. Living donor nephrectomy. A safe procedure

in our center. Experimental and Clinical




Colak T, Manzoor K, Matha V, Kamarad V, Andrysek T,

Rizk S, Hazime A.Switchability of Neoral with Equoral

according to FDA rules and regulations. Experimental


49. Masri MA, Rizk S, Barbari A, Stephan A, Kamel G.A

novel assay for the determination of the in vivo

bioactivity of Tacrolimus and Mycophenolate acid.


vol 2(2): 44.

50. Barbari A, Masri MA, Stephan A, Mourad N, El-Ghoul B,

Kamel G, Kilani H, and Karam A. Cyclosporine A

lymphocyte maximum level: A new alternative

for Cyclosporine A monitoring in Kidney

transplantation. Experimental and Clinical Page 22 of 24

Transplantation 2005; vol 1: 293-300



Colak T, Manzoor K, Matha V, Kamarad V, Andrysek T,

Rizk S, Hazime A. Switchability of Neoral with Equoral

According to FDA rules and regulations. Transplant


Proc Sep 2005; 57(7):2988-93

52. Barbari A, Stephan A, Masri MA, Kamel G, Karam

A, Mourad N, Kilani H, El-Ghoul B. MPA plasma trough

Level: Correlation with clinical Outcome.


3(2):355-60

53. El-Harakeh MA, Barbari A, Stephan A, Saggi S, Kilani

H, Barakeh A. A transplanted kidney surviving total

Vessel occlusion and anuria. Clin Nephrol 2005; 64:159-62

54. Barbari A, Masri MA, Stephan AG, El Ghoul B, S Rizk,

Mourad N, Kamel GS, Kilani HE Karam AS. CsA lymphocyte

maximum level monitoring in de novo kidney transplant

patients: A prospective study. Experimental and Clinical

Transplantation June 2006; vol 4(1): 400-405.

55.Barbari A, Masri M,Stephan A, Rizk S, Bou Khalil L, Kamel G, Mourad .Cyclosporine A Whole

Blood Vs Lymphocyte Maximum Concentration: Correlation with the Immune Response. Experimental


56.Barbari A, Masri M, Stephan A, Rizk S, Bou Khalil L, Kamel G. Tacrolimus Whole blood Vs

Lymphocyte Trough Level: Correlation with the Immune Response. Experimental and Clinical


57.Barbari A, Masri M, Stephan A, Rizk S, Bou Khalil L, Kamel G. Tacrolimus Whole blood Vs

Lymphocyte Trough Level in De novo kidney transplant patients: Clinical relevance. Experimental


58.Masri M, Barbari A, Rizk S. Factors influencing the bioavailability and dosages of

immunosuppressive drugs. Experimental and Clinical Transplantation Dec 2006; vol 4(2): 38.


59.Barbari A, Stephan A and Masri M. Calcineurin inhibitors-free immunosuppression: Risks and

benefits. Saudi J Kid Dis Transplant March 2007; 18(1):1-23.

Page 23 of 24

60.Masri M, Rizk S, Barbari A, Stephan A, Kamel G, M Rost. An assay for the determination of

Sirolimus levels in the lymphocyte of transplant patients. Transplant Proc May 2007; 39

(4):1204-12

61.Barbari A, Masri M, Stephan A, Rizk S, Younan F.A novel approach in clinical

immunosuppression monitoring: Drug lymphocyte level. Experimental Clinical Transplantation 2007;

2: 643-648

62.Stephan A, Barbari A, Younan F. Ethical aspects on organ donation. Experimental Clinical

Transplantation 2007; 2: 633-637.

63.Chammas E, Hussein A, Barbari A, Abou Akl M, Hamoui O, Abouzahr L. Regression of cardiac

lupus under immunosuppressive therapy. Circulation 2008; World Congress of Cardiology, May 2008,

Abstract P1349.

64.Barbari A. Drug lymphocyte level: New perspective in clinical immunosuppression monitoring.

Annals of Transplantation, September 2008, Abstract P 45

65.Barbari A, Masri M, Stephan A, Rizk S, Younan F, Bassil N. Novel simplified approach for

Cyclosporine A therapy monitoring in De novo kidney transplant patients: Time average

Cyclosporine maximum lymphocyte level. Experimental Clinical Transplantation, November 2008,

Abstract P 65.

66.Barbari A, Masri M, Stephan A, Rizk S, Younan F, Bassil N. Time average Cyclosporine maximum

level in stable De novo kiney transplant patients: Two years follow-up. Experimental Clinical

Transplantation, November 2008, Abstract P 161.

67.The declaration of Istanbul on organ trafficking and transplant tourism. Participants in the

International Summit on Transplant Tourism and Organ Trafficking. Exp Clin Transplant. 2008

Sep;6(3):171-9.


68.The Declaration of Istanbul on Organ Trafficking and Transplant Tourism.International Summit

on Transplant Tourism and Organ Trafficking. Clin J Am Soc Nephrol. 2008 Sep;3(5):1227-31.

69.The Declaration of Istanbul on organ trafficking and transplant tourism. Participants in the

International Summit on Transplant Tourism and Organ Trafficking Convened by the Transplantation

Society and International

Page 24 of 24

Society of Nephrology in Istanbul, Turkey, April 30-May 2, 2008. Transplantation. 2008 Oct

27;86(8):1013-8.

70.The Declaration of Istanbul on organ trafficking and transplant tourism. International Summit

on Transplant Tourism and Organ Trafficking. Kidney Int. 2008 Oct;74(7):854-9.

B. RESEARCH PAPERS – NON – PEER REVIEWED

Barbari A. Prolactine micro-adenoma, treatment of

Choice. Study of 15 cases. Faculty of Medicine

Montpellier, France. May 1981.

Antoine Barbari, MD

Vice-president, MESOT

Senior Nephrology Consultant, CMC

Director, Renal Transplant Unit

Rafik Hariri University Hospital

Beirut, Lebanon

Updated: 06/11/09


Professor Van Biesen Wim

Personalia

Born: 19/3/66 at Dendermonde, Belgium

Education:

- High school (1978-1984):

Classics and mathematics, H. Maagd-College Dendermonde ( great distinction)

- University (1984-1991): Doctor in Medicine at the Rijksuniversiteit Gent (great distinction)

Specialisation Internal medicine:

* Two years general internal medicine, Maria Middelares Hospital, St-Niklaas(1991- 1993)

* 6 months general internal medicine UZ Gent (1993-1994)

* 18 months intensive care medicine ( Medical, Surgical, Transplantation, Burns Unit) UZ Gent (1994-1995)

* fellowship Nephrology UZ Gent (1995-1998)

* registration as specialist in internal medicine: 1/10/96

* registration special licence for nephrology: 1/10/97


* Resident Dept of Nephrology UZ Ghent 1998- 2/2001

* Staff member Nephrology UZ Ghent

Assistant-Supervisor 3/2001-2/2002

Chief Clinician 3/2002-

* Teaching professor in medicine (2006- )

Specialized Course Biomedical Engineering (1994-1995): Rijksuniversiteit Gent, great distinction

“Peritoneal Dialysis University Course”, Amsterdam University, 1997

Nominated for the “Maher award of the International Society of Peritoneal Dialysis” Montreal, 2001

Postgraduate Course Biomedical Statistics; Institute of Permanent Education, Faculty of Applied sciences, University Ghent: Great

Distinction, 2001

PhD thesis: University of Ghent

"The role of peritoneal dialysis in an integrated treatment approach of ESRD patients"

promotor: prof N. Lameire; co-promotor: prof Vanholder

29/6/2000: Great distinction

Contemporary profession

* Working at the department of Internal Medicine, Renal Division University Hospital Gent since 1/10/96

* Teaching professor at the faculty of Medicine

Memberships

- Subject editor for Nephrology Dialysis and Transplantation, section Hemodialysis and Peritoneal Dialysis 2005-


- Co-organizer of the Oxford-Ghent summer school on renal replacement and transplantation 2004-.

- Co-chair of the "Commission for International Studies" of the International Society of Peritoneal

Dialysis (2002-)

- Consulting editor for Nephrology Dialysis and Transplantation, NDT-educational section (2002-)

- Member of the editorial board of Peritoneal Dialysis International (2002-)

- Member of the CME-programming committee for the combined EDTA/ISN meeting, Berlin 2003.

- Member scientific committee ISPD/Euro-PD meeting, Amsterdam 2004

- Member “ European working group on residual renal function” (1997-)

- Member “ Commission for theoretical and advanced education in internal medicine” University Hospital Gent”. (1995-)

- Member International Society for Peritoneal Dialysis (1997-)

- Member “European working group on PDC” (1998-)

- Member “registration steering committee” of the Dutch-speaking Belgian organisation for nephrology (1999-).

- Member "working group early referral" of the Dutch speaking Belgian organisation for nephrology.

- Member ISN/ARF task force for disaster relief

- Secretary of the working group on anemia of the QUEST-initiative of the EDTA-ERA (2004-

- Country representative for the ISCHOFF/URREA initiative (DOPPS) (2005-)

- Member Scientific Committee International Society of Peritoneal Dialysis congress 2008 Istanbul

- Member of the board of the Belgische Vereniging voor Interne Geneeskunde (BVIG/SBMI) - Member paper selection committee ISPD meeting Prague 2005

- Member paper selection committee ISN meeting Rio De Janeiro 2007

- Member paper selection committee EuroPD meeting Helsinki 2007

- Member paper selection committee EDTA/ERA meeting Barcelona 2007

- Organiser CME-primer on intensive care nephrology EDTA/ERA meeting Barcelona 2007

-

Reviewer for the following journals:

- New England Journal of Medicine (2)

- The Lancet (1)


- Journal of American Society of Nephrology (1);

- Kidney International (4);

- Critical Care Medicine (27)

- Peritoneal Dialysis International (32);

- Nephrology Dialysis and Transplantation (279);

- American Journal of Medicine (2)

- Blood Purification (4)

- American Journal of Transplantation (2)

- Journal of Epidemiology and Community Health (1)

- Journal of Nephrology (7)

- International Journal of Nephrology and Urology (3)

- Circulation (1)

- Clinica Chemica Acta (4)

- Clinical Journal of the American Society of Nephrology (6)

- American Journal of Kidney diseases (9)

Organiser of the Oxford Dialysis and Transplantation Summer School


List of international publications

1. Vanholder R, Van Biesen W, Hoste E, van der TA, Sever MS. The role of the Renal Disaster Relief Task Force in the

prevention and treatment of Crush syndrome in mass disasters. Acta Clin Belg Suppl 2007; 405-407

2. Vanholder R, Eloot S, Van Biesen W. Do we need new indicators of dialysis adequacy based on middle-molecule

removal? Nat Clin Pract Nephrol 2008;

3. Van Biesen W, Lameire N, Vanholder R. A tantalizing question: Ferrari or Rolls Royce? A meta-analysis on the ideal

renal replacement modality for acute kidney injury at the intensive care unit. Crit Care Med 2008; 36: 649-650

4. Eloot S, Van Biesen W, Dhondt A et al. Impact of hemodialysis duration on the removal of uremic retention solutes.

Kidney Int 2008; 73: 765-770

5. Van LS, Veys N, Verbeke F, Vanholder R, Van Biesen W. The fate of older diabetic patients on peritoneal dialysis:

myths and mysteries and suggestions for further research. Perit Dial Int 2007; 27: 611-618

6. Van Biesen W. Peritoneal dialysis: how we can achieve improvement of PD penetration. Prilozi 2007; 28: 267-274

7. Del Vecchi L, Locatelli F, Martins PM et al. The QUEST initiative anemia study in ESRD: rationale and study

protocol. J Nephrol 2007; 20: 547-553

8. Van Biesen W, Locatelli F, Martins PM et al. The QUEST initiative anemia study in transplant patients: rationale and

study protocol. J Nephrol 2007; 20: 543-546


9. Van Biesen W, Vanholder R, Lameire N. Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol

2006; 1: 1314-1319

10. Van Biesen W, van der Tol A, Veys N et al. The personal dialysis capacity test is superior to the peritoneal

equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J

Am Soc Nephrol 2006; 1: 269-274

11. Van Biesen W, Lameire N, Peeters P, Vanholder R. Belgium's mixed private/public health care system and its impact

on the cost of end-stage renal disease. Int J Health Care Finance Econ 2007; 7: 133-148

12. Verbeke F, Van Biesen W, Peeters P, Van Bortel LM, Vanholder RC. Arterial stiffness and wave reflections in renal

transplant recipients. Nephrol Dial Transplant 2007; 22: 3021-3027

13. Vanholder R, Van Biesen W, Lameire N, Sever MS. The role of the International Society of Nephrology/Renal

Disaster Relief Task Force in the rescue of renal disaster victims. Contrib Nephrol 2007; 156: 325-332

14. Van Biesen W, Veys N, Vanholder R. Intermittent hemodialysis for renal replacement therapy in intensive care: new

evidence for old truths. Contrib Nephrol 2007; 156: 304-308

15. Van Biesen W, Veys N, Verbeke F, Vanholder R. Chronic kidney disease: the cinderella of general medicine.

Epidemiology of and screening for CKD in Belgium. Acta Clin Belg 2006; 61: 319-325

16. Lameire N, Van Biesen W. Decline in peritoneal dialysis publications--no reason for panic. Perit Dial Int 2007; 27:

149-152

17. Vanholder R, Van Biesen W, Verbeke F, Lameire N. The epidemic of cardio-vascular disease in renal failure: where

does it come from, where do we go? Acta Clin Belg 2006; 61: 205-211


18. Van Biesen W, De BD, Verbeke F, Delanghe J, Lameire N, Vanholder R. The glomerular filtration rate in an

apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J 2007; 28:

478-483

19. Van Biesen W, Lameire N, Vanholder R, Mehta R. Relation between acute kidney injury and multiple-organ failure:

the chicken and the egg question. Crit Care Med 2007; 35: 316-317

20. Van Biesen W, Verbeke F, Vanholder R. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments

pro peritoneal dialysis. Nephrol Dial Transplant 2007; 22: 53-58

21. Van Biesen W, Vanholder R, Lameire N. Animal models in peritoneal dialysis: a story of kangaroos and ostriches.

Perit Dial Int 2006; 26: 571-573

22. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol

2006; 2: 364-377

23. Van Biesen W, Vanholder R, Verbeke F, Lameire N. Is peritoneal dialysis associated with increased cardiovascular

morbidity and mortality? Perit Dial Int 2006; 26: 429-434

24. Van Biesen W, Veys N, Vanholder R, Lameire N. The impact of the pre-transplant renal replacement modality on

outcome after cadaveric kidney transplantation: the ghent experience. Contrib Nephrol 2006; 150: 254-258

25. Van Biesen W, Mortier S, Lameire N, De VA. Effects of peritoneal dialysis on the vascular bed of peritoneal

membrane. Contrib Nephrol 2006; 150: 84-89

26. Lameire N, Van Biesen W, Vanholder R. The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us. J Am Soc Nephrol 2006; 17: 923-925


27. Hatamizadeh P, Najafi I, Vanholder R et al. Epidemiologic aspects of the Bam earthquake in Iran: the nephrologic perspective. Am J Kidney Dis. 2006; 47: 428-438

28. Van Biesen W, Eloot S, Verleysen A et al. Clamping of the dialysate outlet line in the Genius dialysis system does not alter dialysate flow or clearances. Nephrol Dial Transplant. 2006; 21: 1069-1072

29. Lameire N, Peeters P, Vanholder R, Van Biesen W. Peritoneal dialysis in Europe: an analysis of its rise and fall. Blood Purif. 2006; 24: 107-114

30. Lameire N, Jager K, Van Biesen W, de Bacquer D, Vanholder R. Chronic kidney disease: a European perspective. Kidney Int Suppl 2005; S30-S38

31. Van Biesen W, Vanholder R, Veys N et al. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant. 2006; 21: 77-83

32. Van Biesen W, Vanholder R, Veys N, Lameire N. Improving salt balance in peritoneal dialysis patients. Perit Dial Int 2005; 25 Suppl 3: S73-S75

33. Lameire N, Van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist--a European survey. Nephrol Dial Transplant. 1999; 14 Suppl 6: 16-23

34. Gillerot G, Goffin E, Michel C et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67: 2477-2487

35. Develter W, De Cubber A, Van Biesen W, Vanholder R, Lameire N. Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients. Artif.Organs 2005; 29: 399-405

36. Van Biesen W, Yegenaga I, Vanholder R et al. Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. J Nephrol 2005; 18: 54-60

37. Van Biesen W, Vanholder R, Veys N, Verbeke F, Lameire N. Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation. Transplantation 2005; 79: 367-368

38. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417-430


39. Vanholder R, Van Biesen W, Lameire N. To pee or not to pee: no more the question in ARF? Nephron Clin Pract. 2005; 99: c61-c62

40. Lameire N, Van Biesen W. Hypervolemia in peritoneal dialysis patients. J Nephrol 2004; 17 Suppl 8: S58-S66

41. Van Biesen W, Vanholder R, Lameire N. In search of the holy grail and the golden fleece. Perit Dial Int 2004; 24: 501-503

42. Lameire N, Van Biesen W, Vanholder R, Hoste E. Intermittent hemodialysis for acute renal failure patients--an update. Contrib.Nephrol 2004; 144: 255-263

43. Van Biesen W, Boer W, De Greve B et al. A randomized clinical trial with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution. Perit Dial Int 2004; 24: 222-230

44. Yegenaga I, Hoste E, Van Biesen W et al. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis. 2004; 43: 817-824

45. Van Biesen W, Lameire N, Veys N, Vanderhaegen B. From curing to caring: one character change makes a world of difference. Issues related to withholding/withdrawing renal replacement therapy (RRT) from patients with important co-morbidities. Nephrol Dial Transplant. 2004; 19: 536-540

46. Van Biesen W, Vanholder R, Lameire N. Dialysis strategies in critically ill acute renal failure patients. Curr Opin Crit Care 2003; 9: 491-495

47. Dequidt C, Vijt D, Veys N, Van Biesen W. Bed-side blind insertion of peritoneal dialysis catheters. EDTNA.ERCA.J 2003; 29: 137-139

48. Glorieux G, Lameire N, Van Biesen W, Dequidt C, Vanholder R. Specific characteristics of peritoneal leucocyte populations during sterile peritonitis associated with icodextrin CAPD fluids. Nephrol Dial Transplant. 2003; 18: 1648-1653

49. Lameire N, Van Biesen W, Vanholder R. Impact of peritoneal dialysis on patient and graft outcome after kidney transplantation. Contrib.Nephrol 2003; 226-241

50. Van Biesen W, Veys N, Vanholder R, Lameire N. New concepts in peritoneal dialysis: new wine in old barrels? Artif.Organs 2003; 27: 398-405


51. Van Biesen W, Carlsson O, Bergia R et al. Personal dialysis capacity (PDC(TM)) test: a multicentre clinical study. Nephrol Dial Transplant. 2003; 18: 788-796

52. Lameire N, Vanholder R, Van Biesen W. Loop diuretics for patients with acute renal failure: helpful or harmful? JAMA 2002; 288: 2599-2601

53. Van Biesen W, Veys N, Vanholder R, Lameire N. The role of APD in the improvement of outcomes in an ESRD program. Semin.Dial 2002; 15: 422-426

54. Van Biesen W, Dequidt C, Vanholder R, Lameire N. The impact of healthy start peritoneal dialysis on the evolution of residual renal function and nutrition parameters. Adv.Perit Dial 2002; 18: 44-48

55. Van Biesen W, Veys N, Vanholder R, Lameire N. Peritoneal-dialysis-related peritonitis: the art of rope-dancing. Nephrol Dial Transplant. 2002; 17: 1878-1882

56. Van Biesen W, Vanholder R, Veys N, Lameire N. Peritoneal dialysis in anuric patients: concerns and cautions. Semin.Dial 2002; 15: 305-310

57. Van Biesen W, De Vriese AS, Carlsson O et al. Comparison of the radioiodinated serum albumin (RISA) dilution technique with direct volumetric measurements in animal models of peritoneal dialysis. Perit Dial Int 2002; 22: 316-322

58. Vanholder R, Van Biesen W. Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif. 2002; 20: 477-480

59. Lameire N, Biesen WV, Vanholder R. Initiation of dialysis--is the problem solved by NECOSAD? Nephrol Dial Transplant. 2002; 17: 1550-1552

60. Lameire N, Wauters JP, Teruel JL, Van Biesen W, Vanholder R. An update on the referral pattern of patients with end-stage renal disease. Kidney Int Suppl 2002; 27-34

61. Van de NN, Verbeke F, Dhondt A et al. The dialytic management of acute renal failure in the elderly. Semin.Dial 2002; 15: 127-132

62. Schoonjans R, Van Vlem B, Vandamme W et al. Gastric emptying of solids in cirrhotic and peritoneal dialysis patients: influence of peritoneal volume load. Eur.J Gastroenterol.Hepatol. 2002; 14: 395-398


63. Davies SJ, Van Biesen W, Nicholas J, Lameire N. Integrated care. Perit Dial Int 2001; 21 Suppl 3: S269-S274

64. Vanholder R, Veys N, Van Biesen W, Lameire N. Alternative timeframes for hemodialysis. Artif.Organs 2002; 26: 160-162

65. Veys N, Biesen WV, Vanholder R, Lameire N. Peritoneal dialysis catheters: the beauty of simplicity or the glamour of technicality? Percutaneous vs surgical placement. Nephrol Dial Transplant. 2002; 17: 210-212

66. Van Biesen W, Van Vlem B, Schepkens H, Lameire N. ACE-inhibitors versus angiotensin receptor blockers for renoprotection: conclusions from the evidence and from the evidence behind the evidence. Acta Clin Belg. 2001; 56: 279-283

67. Van Biesen W, Davies S, Lameire N. An integrated approach to end-stage renal disease. Nephrol Dial Transplant. 2001; 16 Suppl 6: 7-9

68. Van Biesen W, Wiedemann M, Lameire N. End-stage renal disease treatment: a European perspective. J Am Soc Nephrol 1998; 9: S55-S62

69. Dhondt A, Van Biesen W, Vanholder R, Lameire N. Selected practical aspects of intermittent hemodialysis in acute renal failure patients. Contrib.Nephrol 2001; 222-235

70. Ledebo I, Kessler M, Van Biesen W et al. Initiation of dialysis-opinions from an international survey: Report on the Dialysis Opinion Symposium at the ERA-EDTA Congress, 18 September 2000, Nice. Nephrol Dial Transplant. 2001; 16: 1132-1138

71. Lameire N, Van Biesen W. Importance of blood pressure and volume control in peritoneal dialysis patients. Perit Dial Int 2001; 21: 206-211

72. Vanholder R, Van Biesen W, Lameire N. What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol 2001; 12 Suppl 17: S40-S43

73. Vanholder R, Dhondt AM, Van Biesen W. Is Kt/V Urea a Satisfactory Measure for Dosing the Newer Dialysis Regimens? Semin.Dial 2001; 14: 12-14

74. Depner TA, Vanholder R, Dhondt AM et al. Is Kt/V urea a satisfactory measure for dosing the newer dialysis regimens? Semin.Dial 2001; 14: 8-21


75. Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int 2000; 20: 375-383

76. Van Biesen W, Lameire N. General aspects of physiology and pathophysiology of metabolic acidosis in the critically ill. Acta Clin Belg. 2000; 55: 133-140

77. Dhondt A, Vanholder R, Van Biesen W, Lameire N. The removal of uremic toxins. Kidney Int Suppl 2000; 76: S47-S59

78. Lameire N, Van Biesen W, Vanholder R. The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int 2000; 20 Suppl 2: S134-S141

79. Van Biesen W, Vanholder R, Van Loo A, Van D, V, Lameire N. Peritoneal dialysis favorably influences early graft function after renal transplantation compared to hemodialysis. Transplantation 2000; 69: 508-514

80. Van Biesen W, Vanholder R, Debacquer D, De Backer G, Lameire N. Comparison of survival on CAPD and haemodialysis: statistical pitfalls. Nephrol Dial Transplant. 2000; 15: 307-311

81. Van Biesen W, Dequidt C, Vijt D, Vanholder R, Lameire N. Analysis of the reasons for transfers between hemodialysis and peritoneal dialysis and their effect on survivals. Adv.Perit Dial 1998; 14: 90-94

82. Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000; 11: 116-125

83. Van Biesen W, Lameire NH. Residual renal function in automated peritoneal dialysis. Contrib.Nephrol 1999; 129: 229-246

84. Lameire N, Vanholder R, Van Biesen W et al. Evidence-based therapy of acute renal failure. Acta Clin Belg. 1999; 54: 263-273

85. Lameire N, Van Biesen W, Vanholder R. Dialysing the patient with acute renal failure in the ICU: the emperor's clothes? Nephrol Dial Transplant. 1999; 14: 2570-2573

86. Lameire N, Van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist--a European survey. Nephrol Dial Transplant. 1999; 14 Suppl 6: 16-23


87. Van Biesen W, De Vecchi A, Dombros N et al. The referral pattern of end-stage renal disease patients and the initiation of dialysis: a European perspective. Perit Dial Int 1999; 19 Suppl 2: S273-S275

88. Hoeben H, Van Biesen W, Lameire N. Cardiovascular problems in peritoneal dialysis patients: a short overview. Perit Dial Int 1999; 19 Suppl 2: S150-S158

89. Vanholder R, Heering P, Loo AV et al. Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared with hemodialysis. Am J Kidney Dis. 1999; 33: 934-940

90. Lameire N, Van Biesen W, Van Landschoot M et al. Experimental models in peritoneal dialysis: a European experience. Kidney Int 1998; 54: 2194-2206

91. Van Biesen W, Vanholder R, Lameire N. Recent developments in osmotic agents for peritoneal dialysis. Adv.Ren Replace.Ther. 1998; 5: 218-231

92. Van Biesen W, Vanholder R, Vogelaers D et al. The need for a center-tailored treatment protocol for peritonitis. Perit Dial Int 1998; 18: 274-281

93. Lameire N, Van Biesen W, Vanholder R, Colardijn F. The place of intermittent hemodialysis in the treatment of acute renal failure in the ICU patient. Kidney Int Suppl 1998; 66: S110-S119

94. Van Biesen W, Sieben G, Lameire N, Vanholder R. Application of Kohonen neural networks for the non-morphological distinction between glomerular and tubular renal disease. Nephrol Dial Transplant. 1998; 13: 59-66

95. Lameire N, Van Biesen W, Dombros N et al. The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality. Perit Dial Int 1997; 17 Suppl 2: S161-S166

96. Lameire N, Van Biesen W. The impact of residual renal function on the adequacy of peritoneal dialysis. Perit Dial Int 1997; 17 Suppl 2: S102-S110

97. Van Biesen W, Faict D, Boer W, Lameire N. Further animal and human experience with a 0.6% amino acid/1.4% glycerol peritoneal dialysis solution. Perit Dial Int 1997; 17 Suppl 2: S56-S62


98. Vanholder R, Van Biesen W, Ringoir S. Contributing factors to the inhibition of phagocytosis in hemodialyzed patients. Kidney Int 1993; 44: 208-214

99. Vanholder R, Dell'Aquila R, Jacobs V et al. Depressed phagocytosis in hemodialyzed patients: in vivo and in vitro mechanisms. Nephron 1993; 63: 409-415

100. Vanholder R, Van Biesen W, Van Lanschoot N, Waterloos MA, Ringoir S. Relationship between phagocyte metabolic function and years of maintenance dialysis. ASAIO Trans. 1990; 36: M469-M472

Thesis : speciale opleiding klinische en biomedische ingenieurstechnieken:

Neurale netwerken in de geneeskunde: toepassing van de neurale netwerktechnologie als diagnostisch hulpmiddel in de nefrologie: thesis voor

de opleiding biomedische en klinische ingenieurstechnieken, academiejaar 1994-95. Promotoren: Prof R. Vanholder, Prof. L. Boullaert, G.

Sieben.

Chapters in books

* Slow low efficiency daily dialysis and hybrid renal replacement therapies for acute renal failure in the intensive care unit. Van Biesen W.,

Lameire N. in Intensive Care in Nephrology, edited by Murray P., Brady H. and Hall J., Taylor and Francis, London and New York, 2006, 213-

223.

* SLEDD and hybrid renal replacement therapies for acute renal failure in the ICU. Van Biesen, W. and Lameire, N. J.L Vincent. Yearbook of

Intensive Care and Emergency Medicine. (ISBN 3-540-44382-7), 663-678. 2003.

* Long-term peritoneal dialysis: does a spell of peritoneal dialysis prolong survival on hemodailysis; N.Lameire and W. Van Biesen in:

Complications of long term dialysis, E. Brown, P. Parfrey, eds, Oxford University Press, Oxford, 1998, pp 274-297.


* Pharmalogical alterations of peritoneal transport rates and pharmacokinetics in peritoneal dialysis. N. Lameire, W. Van Biesen, P. Hiszel, M.

Bogaert, in : R. Gokal, R. Kanna, R. Krediet, K. Nolph, eds, Textbook of peritoneal dialysis, second edition, Kluwer academic publishers, 2000,

chapter 7

* Economic issues, referral patterns and choice of treatment modality of end stage renal disease in Europe. N. Lameire, W. Van Biesen, M.

Wiedemann, in: Complications of Dialysis, N. Lameire and R. Metha, eds, M Dekker publishers, New York, 2000.

* Outcomes and intermodality transfers in patients on renal rplacement therapy. P. Blake, W. van Biesen, N. Lameire, R. Maiorca. In :

Complications of Dialysis, N. Lameire and R. Metha, eds, M Dekker publishers, New York, 2000.


Peter J. Blankestijn

Office address Department of Nephrology and Hypertension

Room F03.226

University Medical Center

PO Box 85500

3508 GA Utrecht

the Netherlands

E-mail [email protected]

Education and working experience

1974 – 1981 medical school, Erasmus University Rotterdam

1981 – 1982 house officer department of general surgery Zuiderziekenhuis Rotterdam

1982 – 1991 resident internal medicine and staff member on the department of internal medicine

University Hospital Rotterdam (head Prof. Dr. M.A.D.H. Schalekamp)


from 1991 Associate professor on the department of Nephrology and Hypertension of the University

Hospital Utrecht

1991 PhD Thesis, "Adrenaline and hypertension", Erasmus University Rotterdam

1992 Registration as Clinical Hypertension Specialist (European Society of Hypertension)

Research

Research activities mainly include studies in humans.

Subjects are:

- hypertension, with special interest for renal hypertension and the sympathetic nervous system.

- treatment and prevention of complications of chronic kidney disease patients

- hemodialysis techniques

- treatment and prevention of complications of hemodialysis treatment

Principal investigator of several multicenter studies, including CONTRAST and MASTERPLAN.

Grants

Numerous research grants, including Dutch Kidney Foundation, Netherlands Heart Foundation, ISN/Baxter

Extramural Grant Program, Dutch government and dialysis/pharmaceutical companies.

Publications

Over 120 in peer reviewed journals.

Several chapters in books and UpToDate


Memberships

American Society of Nephrology

International Society of Nephrology

European Dialysis Transplant Association

Committees (selection)

Past and present: member of several advisory boards of the Dutch Kidney Foundation

Past and present: member (including chairman) of several committees and boards of the Netherlands

Federation of Nephrology

Member of Scientific Advisory Board of the European Dialysis and Transplant Association (EDTA).

Member of Kidney Disease Improving Global Outcome (KDIGO) working party on hypertension.

Selection on publications in 2009 and 2010

- HJ Huibregts, ML Bots, CH Wittens, YC Schrama, PJ Blankestijn. Access blood flow and the risk of

complications in mature forearm and upper arm arteriovenous fistulas. Blood Pur 2009; 27:212-9

- EL Penne, J Neumann, II Klein, PL Oey, ML Bots, PJ Blankestijn. Sympathetic hyperactivity and

clinical outcome in chronic kidney disease patients during standard treatment. J Nephrol 2009; 22: 208-15.

- EHJ Voormolen, AK Jahrome, LW Bartels, FL Moll, WP Mali, PJ Blankestijn. Non-Maturation of Arm

Arteriovenous Fistulae for Haemodialysis Access: A Systematic Review of Risk Factors and Results of

Early Treatment. J Vasc Surg 2009; 49: 1325-36.


- L Siddiqi, JA Joles, G Grassi, PJ Blankestijn. Is kidney ischemia the central mechanism in parallel

activation of the renin and sympathetic system? J Hypertens 2009; 27: 1341-49.

- L Siddiqi, PJ Blankestijn. Sympathetic activity and clinical outcome in dialysis patients. Hypertension

2009; 54: e8.

- EL Penne, NC van der Weerd, ML Bots, MA van den Dorpel, MPC Grooteman, R Lévesque, MJ Nubé,

PM ter Wee, PJ Blankestijn, on behalf of the CONTRAST investigators. Patient and treatment related

determinants of convective volume in post-dilution hemodiafiltration in clinical practice. Nephrol Dial

Transplant 2009; 24: 3493-99.

- EL Penne, L Visser, MA. van den Dorpel, NC. van der Weerd, AHA Mazairac, BC. van Jaarsveld,

MG. Koopman, P Vos, GW. Feith, TK. Kremer Hovinga, HW. van Hamersvelt, IM. Wauters, ML. Bots, MJ.

Nubé, PM. ter Wee, PJ. Blankestijn, MP.C. Grooteman. Microbiological quality of substitution fluids for

online hemodiafiltration in routine clinical practice. Kidney Int 2009; 76: 665-72.

- M Gritters-van den Oever, M Grooteman, PC Bartels, PJ Blankestijn, ML Bots, MA van den Dorpel,

M Schoorl, PM ter Wee, MJ Nube. Post-dilution haemodiafiltration and low-flux haemodialysis have

dissimilar effects on platelets: a side study of CONTRAST. Nephrol Dial Transplant 2009; 24: 3461-8.

- EL Penne, T van Berkel, NC van der Weerd, MPC Grooteman, PJ Blankestijn. Optimizing

hemodiafiltration: tools, strategy and remaining questions. Nephrol Dial Transplant 2009; 24: 3579-81.

- EL Penne, NC van der Weerd, MA van den Dorpel, MPC Grooteman, R Lévesque, MJ. Nubé, ML Bots,

PJ Blankestijn, PM ter Wee for the CONTRAST investigators. Short term effects of online hemodiafiltration

on phosphate control: results from the Convective transport study. Am J Kidney Dis 2010; 55: 77-87.


- EL Penne, NC. van der Weerd, PJ. Blankestijn, MA van den Dorpel, MPC Grooteman, MJ. Nubé, PM. ter Wee, R Lévesque, ML. Bots for

the CONTRAST investigators. Role of residual renal function on decrease of serum 2-microglobulin levels in patients on online

hemodiafiltration. Clin J Am Soc Nephrol 2010; 5: 80-6.

- I Ledebo, PJ Blankestijn, Hemodiafiltration: optimal efficiency and safety. Nephrol Dial Transplant

Plus 2010; 3: 8-16.

- KE Jie, A. Zaikova, MW. Bergevoet, PE. Westerweel, M Rastmanesh, PJ Blankestijn, WH Boer, B

Braam, MC Verhaar. Progenitor cells and vascular function are impaired in patients with chronic kidney

disease. Nephrol Dial Transplant 2010

- PJ Blankestijn, I Ledebo, B Canaud. Hemodiafiltration, clinical evidence and remaining questions.

Kidney Int 2010

- L Siddiqi, PJ Blankestijn. Reduction of sympathetic hyperactivity by agents that inhibit the renin

angiotensin aldosterone system. Curr Hypertens Rev 2010

- HJTAM Huijbregts, GJ de Borst, WB. Veldhuis, HJM Verhagen, E Velema, MAAJ van den Bosch,

FL Moll, PJ Blankestijn, G Pasterkamp. Preventative cryoplasty of the venous anastomosis for reduction of

intimal hyperplasia in a validated porcine arteriovenous graft model. Eur J Vasc Endovasc Surg 2010 - AD van Zuilen, PJ Blankestijn, M van Buren, MA ten Dam, KA Kaasjager, G Ligtenberg, YW Sijpkens, HE Sluiter, PJ van de Ven, G

Vervoort, LJ Vleming, ML Bots, JF Wetzels on behalf of the MASTERPLAN study Group. Quality of care in chronic kidney disease patients is

determined by hospital specific factors. Nephrol Dial Transplant 2010

- L Siddiqi, NH Prakken, BK Velthuis, MJ Cramer, LP Oey, P Boer, M Bots, PJ Blankestijn.

Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite

antihypertensive treatment. Nephrol Dial Transplant 2010

Bernard Canaud, MD


_____


Bernard Canaud, MD

Born on November 6, 1949

In Casablanca, Morocco

French citizen

Married, 4 Children

Address 9, Rue des Carmélites

34000 Montpellier - France

Phone Private 04 67 52 44 18

Office 04 67 33 84 95

Fax Private 04 67 54 45 65

Office 04 67 60 37 83

E-mail [email protected] (home)

[email protected] (office)

Ordre des Médecins n° 34-5606


Titles and Functions

School of Medicine, 1968 - 1975

Resident in Medicine, 1974 - 1975

Intern in Medicine, Nephrology and Critical Care, 1975 - 1981

Graduate in Medicine, Montpellier Medical School, 1980

Specialist in Nephrology, 1981

Master in Bioenergetic and Nutrition, (University of Sciences, Montpellier) 1986

Assistant, Critical Care Medicine (Montpellier University) 1981 - 1984

Assistant Professor, Nephrology (Montpellier University) 1984 - 1988

Professor of Nephrology, (School of Medicine, Montpellier University, Lapeyronie Hospital) 1990

Head of the Nephrology Intensive Care and of Dialysis Units, 1989

Head of the Nephrology Department, 1998

Scientific Societies

French Society of Nephrology

French Society of Dialysis

French Society of Critical Care Medicine

European Dialysis and Transplant Association, EDTA

American Society of Nephrology, ASN

International Society of Nephrology, ISN

International Society of Blood Purification, ISBP

American Society for Artificial Internal Organs, ASAIO

Member of Editorial Board


Néphrologie

Journal of Nephrology

Blood Purification

American Journal of Kidney Diseases

Nephrology Dialysis Transplantation

Research Fields

Development of extracorporeal treatment modalities

Dialysis quantification: on-line and off-line monitoring

Mathematical modeling of dialysis and related fields

Vascular access development: temporary and permanent catheters

Nutritional assessment and support in renal patients

Biocompatibility of dialysis system: membrane, dialysate

Water treatment system purification: ultrapure water and dialysate

Development of on-line production of substitution fluid for hemodiafiltration and hemofiltration

Treatment modalities for acute renal patients

Treatment of refractory congestive heart failure patients by hemofiltration

Erythropoietin evaluation and modeling

Computerized and data acquisition system for dialysis unit

agenda 7 fme mea nephrology forum hilton vienna 1st fileagenda 7th fme mea nephrology forum hilton...

Documents